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ABSTRACT OF DISSERTATION

The Acute Effects of Nut Ingestion on Plasma Levels of Nutrients, Polyphenols and
Biomarkers of Antioxidant Status
by
Setareh Torabian Esfahani
Doctor of Public Health Candidate in Nutrition
Loma Linda University, Loma Linda University, 2005
Ella H. Haddad, Chair

Nuts are rich sources of polyphenolic compounds and nutrients, which have antioxidant
capacity. To assess the acute effect of treatment diet (75% of energy from nuts (walnut or
almond) and control diet (habitual diet with no nut consumption) in healthy subjects on
plasma total phenol content, antioxidant capacity and plasma lipid peroxidation.
Thirteen subjects participated in the crossover design study. After an overnight fast,
walnut, almond and a control diet, in form of smoothies, were consumed by the study
subjects. Each subject participated on three occasions one week apart, consuming one of
the smoothies each time. Blood samples were obtained at intervals up to 3.5h after
consumption of the smoothies. Results showed that within 90 minutes of consumption of
the walnut and almond, there was a significant increase in plasma total phenol content.
Antioxidant capacity of plasma determined by the ferric reducing capacity of plasma
(FRAP) and oxygen radical absorbance capacity (ORAC) reached its highest point at 150
min post-consumption of
m

nut diet. Also, a gradual reduction in the susceptibility of plasma to lipid peroxidation
was observed 90 minutes after nut diets. No changes were observed following
consumption of control diet. We concluded that consumption of nuts raises total phenol
concentration, enhances the antioxidant capacity of plasma, and reduces plasma lipid
peroxidation. These findings conclude that in addition to the favorable lipid profile of
nuts, their phenolic content must now be considered as a potential contributor to the
apparent antithrombic, antioxidant, anti-ischemic effects as well.
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CHAPTER 1
INTRODUCTION
A. Statement of the Problem
A correlation between nut consumption and a reduced incidence of both fatal and
nonfatal ischemic heart disease has been observed in many different studies (Fraser,
Sabate, Beeson & Strahan 1992; Hu et ah 1998; & Kushi et al. 1996). The mechanisms
investigated in all these studies were mainly dependent on cholesterol lowering effects of
nuts, while tree nuts are rich in many nutrients that may reduce risk of disease by
mechanisms that are independent of cholesterol lowering. These include vitamin E and a
wide range of polyphenol compounds that potentially contribute to antioxidant capacity.
The beneficial effect of nut intake may rely not only on blood lipid changes, but also on
antioxidant nutrients and bioactive components. In different experiments, it has been
shown that selected polyphenols possess protective effects on the cardiovascular system,
as well as anticancer, antiviral and antiallergic properties. Several papers have provided
evidence of a link between polyphenol intake and the risk of cardiovascular disease in
man. Numerous in vitro studies using a variety of oxidation methods and measurements
have shown that polyphenols from red wine (Teissedre et al. 1996), green tea (Yoshida et
al. 1999), and chocolate (Waterhouse, Shirley, & Donovan, 1996) can inhibit LDL
oxidation. Many in vivo studies (Serafmi, Ghiselli and Ferro-Luzzi, 1996; Seeram et al.
2006; Fuhrman, Lavy and Aviram 1995; Whitehead et al. 1995; Serafmi et al. 2003; Rein
et al. 2000; Zenebe & Pechanova, 2002) also showed the contribution of polyphenols
found in a variety of fruits, vegetables, tea, wine and chocolate to human health.
However, little is known about the contribution of nut polyphenols to the body’s
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antioxidant status and cardiovascular protection. More investigation is required to
demonstrate the impact of nut ingestion on plasma polyphenol levels and plasma
antioxidant status.
B. Purpose of the Study
The primary purpose of this study was to extend our understanding of the
polyphenol compounds in nuts and the mechanisms by which they protect against disease
progression by examining the effect of nut consumption on in vivo changes in lipid
peroxidation and antioxidant markers. Second, this study compared the bio availability of
polyphenols in walnuts and almonds. Third, this study investigated the time trend of
plasma total polyphenol levels before and after ingestion of nut-containing meal in order
to obtain plasma peak concentration.
C. Hypotheses
This study tested four hypotheses regarding the bioavailability of nut polyphenols
and antioxidant capacity of walnuts and almonds. The hypotheses were: (1) the plasma
polyphenol concentration after consumption of treatment meal (75% nut-containing diet)
will be significantly higher than the control meal; (2) plasma polyphenols concentration
will gradually increase after consumption of the treatment meal, but no significant change
is expected after consumption of the control meal; (3) plasma antioxidant capacity will be
significantly higher in the treatment group compared to the control group; and (4) lipid
peroxidation will be significantly inhibited in the treatment group compared to the control
group.
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D. Research Questions
1. What are the effects of nut-containing meal on postprandial levels of serum lipid
peroxides and on serum antioxidant capacity?
2. What are the bioavailability of nut polyphenolic compounds and their peak
plasma concentrations?
3. What are the postprandial serum antioxidant capacity and polyphenolic levels of
meals based on different nuts (walnuts and almonds)?
E. Significance to Nutrition
Advances in understanding the role of free radicals in the development of many
chronic diseases suggest a potential health-promoting role of dietary antioxidants.
Epidemiological studies have shown that consumption of phenol-rich foods such as fruits
and vegetables correlates with reduced coronary heart disease mortality (Friedman &
Kimball, 1986 and Knekt, Jarvinen, Reunanen & Maatela, 1996). In this study, we
extended the previous observations to polyphenols in nuts. Tree nut polyphenols might be
effective inhibitors of lipid peroxidation and have antioatherogenic potential. Thus, the
study results serves as evidence that shows the anti-oxidative effect of nuts in addition to
their favorable lipid profile. Moreover, applications of this knowledge include
recommendations by health professionals to encourage individuals to consume nuts in
moderate amounts. Also, the results of current study can assist researchers to expand the
future research in the area of nut consumption and antioxidants capacity.
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CHAPTER 2
LITERATURE REVIEW

Consumption of tree nuts such as almonds and walnuts was common among
Mediterranean populations for centuries. However, only recently has interest in nuts as an
important food group been considered. Nuts are an important source of healthful dietary
lipids, protein, minerals, and a potentially rich source of phytochemicals. In general
phytochemicals are found in fruits, vegetables, nuts, seeds, grains and legumes, however,
the group of phytochemicals found in nuts are mostly polyphenolic compounds.
Polyphenols constitute a numerous and ubiquitous group of plant components and are an
integral part of both human and animal diets. Ranging from simple phenolic molecules to
highly polymerized compounds with molecular weights of greater than 30,000 Da, the
occurrence of this complex group of substances in plant foods is extremely variable
(Bravo, 1998). All plant phenols are derived from the common intermediate
phenylalanine, or its closer precursor shikimic acid, through the shikimic pathway in
plants (Arts and Hollman, 2005). Polyphenols exhibit a wide range of properties,
depending on their particular structures (Cheynier, 2005). They are formed to protect
plants from photosynthetic stress and reactive oxygen species. Early interest in
polyphenols was related to their “anti-nutritional” effects, i.e., decreasing absorption and
digestibility of food through their ability to bind proteins and minerals (Lambert et al.
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2005). Current interest is focusing on their beneficial health effects. Polyphenols are
currently believed to exert cardioprotective effects in humans via their ability to inhibit
oxidation of lipoproteins (Meyer & Frankel 2001) and also their free radical scavenging
abilities which is directly associated with the risk of cancer.
A. Chemistry, Classification and Distribution
Polyphenols are one of the most numerous and widely distributed groups of
natural compounds in the plant kingdom, with more than 8000 phenolic structures
currently known (Harbome, 1993). Natural polyphenols can range from simple
molecules, such as phenolic acids, to highly polymerized compounds, such as tannins.
The chemical structure of polyphenols will affect their biological properties such as
bioavailability, antioxidant activity and specific interactions with cell receptors (Scalbert
and Williamson, 2000). Polyphenols occur primarily in conjugated form, with one or
more sugar residues attached to hydroxyl groups. The associated sugars can be present as
monosaccharides, disaccharadies, or even oligosaccharadies (Bravo, 1998). The
antioxidant potentials of polyphenols are closely related to the number of hydroxyl
groups that they possess. Polyphenols may be classified into different groups as a
function of the number of phenol rings that they contain, the structural elements that bind
the rings to one another (Manach et al. 2004), or based on the nature of carbon skeleton
(Scalbert & Williamson, 2000). The main classes of polyphenols are: phenolic acids,
flavonoids, and the less common stillbenes, lignans, and tannins. Figure 1. (adopted from
Manach et al. 2004) shows the chemical structures of selected polyphenols and Figure 2.
shows the common classifications of polyphenols. A short description of the various
classes and their distribution in foods are provided.
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1. Phenolic adds
Phenolic acids are abundant in foods. Two classes of phenolic acids can be
distinguished: derivatives of benzoic acid and derivatives of cinnamic acid (Manach et al.
2004). According to Manach et al. (2004) hydroxyl benzoic acids can be found in two
different forms, free and esterified. The two major dietary hydroxylbenzoic acids are
ellagic acid and gallic acid, which are usually derived from hydrolyzable tannins and are
found in raspberries, strawberries, grape juice, and nuts (King & Young 1999). However,
due to their low availability in plants eaten by humans, they have not been extensively
studied and are not currently considered to be of great nutritional interest.
The derivatives of hydroxycinnamic acids are more frequent and consist mainly of
caffeic, ferulic, chlorogenic, and neochlorogenic acids (Manach et al. 2004, King &
Young, 1999). Among all, caffeic acid is the most frequently encountered phenolic acid
(Scalbert & Williamson, 2000). According to Kroon et al. 2004, ferulic acid is associated
with dietary fiber and is linked through ester bonds to hemi-cellulose and one of the main
food sources of this polyphenol is wheat bran (5 mg/g). Many different fruits and
vegetables contain phenolic acids in general, but blueberries, kiwis, plums, cherries, and
apples have the highest content of hydroxycinnamic acids between 0.5-2 g /kg fresh wt
(Macheix et al. 1990).
2. Flavonoids
Flavonoids are the most common and widely distributed group of plant phenols.
Their common structure is that of diphenylpropanes and consists of two aromatic rings
linked through three carbons that usually form an oxygenated heterocycle (Bravo, 1998).
King & Young in 1999, divided flavonoids into two main groups, anthocyanins and
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anthoxanthines. Anthocyanins are molecules of red, blue, and purple pigment. Bravo
(1998) stated that “The term anthocyanin refers to the glycosides of anthocyanidin (e.g.,
pelargonidin, malvidin, cyanidin). In addition to glycosylation, common linkages with
aromatic and aliphatic acids, as well as methyl ester derivatives, occur.” Anthocyanins
and polymeric pigments formed from anthocyanins by condensation with other
flavonoids are responsible for the color of red wine (Mazza & Maniati, 1993). The
second group are the anthoxanthines, which include flavonols, flavones, flavanols,
flavanones and isoflavones are colorless or white to yellow molecules (King & Young,
1999). Among the flavonoids, flavones (e.g., apigenin, luteolin, diosmetin), flavonols
(e.g., quercetin, myricetin, kaempferol), and their glycosides are the most common
compounds. They are widespread in the plant kingdom, with the exception of algae and
fungi (Bravo, 1998). Quercetin is a principal phenolic compound of plants and
quantitatively the most important dietary flavonoid (King & Young 1999). Foods with
particularly high amount of flavonols are onions, apples, kale, and tea (Hertog et al.
1993). Bioavailability of flavonoids is different among different foods (Hollman et al.
1997). Flavones are less common and were identified in sweet red pepper (luteolin) and
celery (apigenin) (Hertog et al. 1992). Flavanols exist in both the monomer form
(catechins) and the polymer form (proanthocyanidins) (Manach et al. 2004). Catechins
are found in many types of fruits and apricots, which contain 250 mg/kg fresh weight, are
one of the richest source. They are also present in red wine (up to 300 mg/L), but green
tea and chocolate are by far the richest sources (Lakenbrink et al. 2000). During
fermentation of black tea, catechin will change into more complex polyphenol due to the
oxidation and heating process, which results in the reduction of polyphenol quantities by
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50% (Ding et al. 1992). Proanthocyanins, or polymeric flavanols are present in plants as
complex mixtures of compounds with an average degree of polymerization between 4
and 11 (Clifford, 2000). They are responsible for the astringency of food and are usually
present in association with flavanol catechin (Scalbert & Williamson, 2000). Flavanones
such as hesperetin, eriodictyol and naringenin can be found in citric fruit. Isoflavones are
found in almost all legume family species and in especially high amounts in soy beans
(King & Young, 1999). The two major classes of isoflavones are genistein and daidzein.
The total amount of isoflavones in dry soybeans ranges from 1600 to 2400 mg/kg
(Frankel et al. 1995). According to Frankel et al (1995), isoflavones are heat stable,
slightly water soluble and very soluble in alcohol.
3. Lignans
Lignans are formed from two phenylpropane units (Manach et al. 2004). The
foods that contain considerable amount of lignins are flax seed, flax seed oil (Axelson et
al. 1982) and linseed (Adlercreutz & Mazur, 1997). Cereals, grains, fruit, and certain
vegetables also contain traces of these same lignans, but concentrations in linseed are a*
1000 times as high as concentrations in these other food sources (Adlercreutz & Mazur,
1997). Scalbert & Williamson (2000) stated “when lignans are fed to humans or animals,
they are metabolized by the gut microflora.” Lignans are also recognized as
phytoesterogens due to their esterogen agonist and antagonist properties (Heinonen et al.
2001).
4. Stillbenes
Stillbenes are present in a very low quantity in human diet. One member of the
stillbene family, resveratrol, received attention for its anti-carcinogenic properties (Jang
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et al. 1997). However due to a very small amount of this component in the human diet,
any protective effect of this molecule is unlikely at normal nutritional intakes (Manach et
al. 2004)
5. Tannins
Unlike the previously described groups of plant phenolics, tannins are compounds
of intermediate to high molecular weight. Tannins with a molecular mass of up to 30,000
Da have been found in carob pods (Leguminosae) (Ragan & Glombitza, 1986). Tannins
are highly hydroxylated molecules and can form insoluble complexes with carbohydrates
and protein (Bravo, 1998). Tannins react with mouth proteins, thereby causing the taste
sensation we know as astringency (King & Young, 1999). Plant tannins can be
subdivided into two major groups: (1) hydrolyzable and (2) condensed tannins. A third
group of tannins, the phlorotannins, are found only in marine brown algae and are not
commonly consumed by humans (Ragan & Glombitza, 1986). Condensed tannins are
polymers of catechin or epicatechin and are found mainly in fruit, grains, and legumes.
Hydrolyzable tannins are polymers of gallic acid or ellagic acid and are found in berries
and nuts (King & Young, 1999).
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Figure 1. Chemical structure of selected polyphenols (adopted from Manach et al.2004)
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Figure 2. Polyphenol Classification
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B. Metabolism
1. Absorption and Bioavailability of Polyphenols
From a nutritional perspective, it is important to consider not only the daily intake
of dietary polyphenols but also the bioavailability of those ingested polyphenols. The
attainment of potential health-related effects will significantly depend on polyphenol’s
behavior in the digestive tract. However, little is known about the absorption of
polyphenols, their retention in the body after absorption, and their biologic significance.
The enormous variability of this group of substances, as well as their occurrence in plant
materials as a complex mixture of phenolic compounds, creates great difficulties in the
study of their bioavailability and their physiologic and nutritional effects (Bravo, 1998).
Various direct and indirect evidences of polyphenol bio availability have been used for a
wide array of foods such as tea (Serafini et al. 1996), red wine (Duthie et al. 1998), and
apple juice (Young et al. 1999). The direct indicator of bioavailability is estimated by
includes measuring the concentration of polyphenols in plasma and urine after ingestion
of polyphenol-rich foods. The indirect indicator of absorption is the increase in the
antioxidant capacity of the plasma after the ingestion of polyphenol-rich food.
Although polyphenols are consumed daily and can be found in almost all fruits and
vegetables, they are not highly active components in the human body. Manach et al.
(2004) mentioned four reasons for the low activity of polypenols in vivo, (1) their rapid
elimination; (2) their low intrinsic activity; (3) their poor absorption from the intestine;
and (4) their fast metabolism. The absorption and metabolism of food polyphenols are
determined primarily by their chemical structure, which depends on factors such as the
degree of glycosylation/ acylation, their basic structure (i.e., benzene or flavone
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derivatives), conjugation with other phenolics, molecular size, degree of polymerization,
and solubility (Bravo, 1998).
In general, polyphenols can be found in four different forms in food, as aglycones
(acylated), esters, polymers, and glycosides. Aglycones or acylated forms appear to be
the only form which can pass through biologcal membranes and be absorbed without
hydrolysis. The other three forms need to get hydrolyzed by intestinal enzymes or
metabolized by colonic microflora prior to absorption (Manach et al. 2004). For
glycosylated polyphenols, according to Scalbert and Williamson (2000), the predicted
effect of the attached moiety on passive diffusion across biological membranes suggests
that removal of the hydrophilic moiety will usually be necessary for passive diffusion
across the small intestine brush border to happen. It is believed that most polyphenols are
probably too hydrophilic to penetrate the gut wall by passive diffusion and they need
membrane carriers, which have not been identified (Manach etal. 2004). Scalbert and
Williamson (2000) concluded that the first step of metabolism for polyphenol absorption
should be removal of the sugar by glycosidase enzymes. Glycosidase activities can occur
in three different sites, (1) in the food itself; (2) in the small intestine; and (3) in the colon
by colonic micrflora. Gee et al. (1998) stated that most of the glycosides probably resist
acid hydrolysis in the stomach and thus arrive intact in the duodenum. Hollman et al.
(1995) suggested that glycosides could be transported into enterocytes by the sodiumdependent glucose transporter SGLT1, and then hydrolyzed by specific glycosidases.
According to Day et al. (2000) and Scalbert and Williamson (2000), two main
glycosidases exist in the human small intestine, lactase phlorizin hydrolaze (LPH) and
cystolic-|3-glucosidase (CBG), both of which play an important role in the hydrolysis of
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polyphenols in the small intestine. Some other glycosidases can be secreted by colonic
micro flora and those polyphenols which are not absorbed in the small intestine might by
hydrolyzed by bacteria in the colon and get reabsorbed. Studies suggest that intact
glycosides of some polyphenols such as daidzein and genistein are not recovered in
plasma or urine after ingestion as pure compounds (Manach et al. 1998, Wittig et al.
2001, Setcell et al. 2002).
For ester polyphenols, such as phenolic acids (hydroxycinnamic acid, ferulic, and
caffeic acids), they can be esterified to sugars, organic acids, and lipids. However, there
are no esterases in human tissues able to release the simple components of ester
polyphenols for absorption (Plumb et al. 1999). Therefore, this type of polyphenol can
not be released by mammalian endogenous enzymes and requires release by enzymes of
the colonic micro flora (Kroon et al. 1996). As a general mle, absorption occurs less
readily in the colon than in the small intestine because of the smaller exchange area and a
lower density of transport systems. This results in slower absorption with low efficiency
of polyphenols, which are absorbed in the colon, compared to those absorbed in the small
intestine (Manach et al. 2004). Finally, for the polymer forms of polyphenols, such as
proanthocyanidines with high molecular weight, absorption barely happens in the small
intestine (Scalbert and Wiliamson, 2000). Although proanthocyanidines are among the
most abundant dietary polyphenols (Manach et al. 2004), they are very poorly absorbed
and may exert only local activities in the gastrointestinal tract or activity mediated by
phenolic acids produced through microbial degradation. A study by Halliwell and
coworkers (2000) concluded that the local activities of proanthocyanidines may be
important because the intestine is particularly exposed to oxidizing agents and may be
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affected by inflammation. Polyphenol concentrations in the colon can reach several
hundred micromoles per liter (Scalbert and Williamson, 2000). However, absorption of
proanthocyanidines through the gut barrier is scarce (Santos-Buelga and Scalbert, 2000).
Direct and indirect interaction between polyphenols and various foods has been
investigated. Manach et al. (2004) suggested that direct interactions between
polyphenols, proteins, and polysaccharides in food may affect absorption. Additionally,
diet may influence some parameters of gut physiology such as pH, intestinal
fermentation, biliary excretion, and transit time, and these might indirectly have
consequences on the absorption of polyphenols. Inconsistent information has been
provided about interaction between protein in milk and polyphenol absorption from black
tea. Serafim and his coworkers in 1996 reported that the addition of milk to black tea
abolished the increase in antioxidant potential that was seen when tea was consumed
without milk. On the other hand, some other studies showed that protein in milk had no
effect on bioavailability of polyphenols found in black tea (van het Hof et al., 1999 and
Hollman et al, 2001). Another study showed that the positive effect of alcohol in red
wine on polyphenol absorption was due to increasing their solubility (Kanner et al. 1994).
Pietta et al. (1998) reported an improved absorption of specific flavonoids in the presence
of fats. Catechin from green tea and oligomeric proanthocyanidins from grape seeds are
absorbed to a greater extent when administrated as phospholipid complexes rather than
free form.
Most of the studies conducted have reported that absorption of polyphenols are
inhibited if taken with any kind of food. Therefore, high plasma polyphenol levels are
reached only if pure polyphenols in form of supplements are taken separately from foods.
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2. Deconjugation and Reconjugation of Polyphenols
According to Manach et al. (2004), once polyphenols are absorbed in the form of
simple polyphenols or aglycones, they can undergo either of the three main types of
conjugation: methylation, sulfation, and glucuronidation or a combination of all three.
This is a metabolic detoxification process common to many xenobiotics that restricts their
potential toxic effects and facilitates their biliary and urinary elimination by increasing
their hydrophilicity. The conjugation mechanisms are highly efficient, and aglycones are
generally either absent in blood, or present in low concentrations after consumption of
nutritional doses (Piskula, 2000). The relative importance of the three types of
conjugation appears to vary according to the nature of the substrate and the dose ingested.
Sulfation is generally a higher-affinity, lower capacity pathway than is glucuronidation,
so that when the ingested dose increases, a shift from sulfation toward glucuronidation
occurs (Koster et al. 1981). The steps of conjugation process are controlled by the
specificity and distribution of the enzymes that catalyze the reactions (Scalbert and
Williamson, 2000). For example, for methylation of catechin, caffeic acid, and luteolin,
catechol-O-methyl transferase is an active enzyme, which catalyzes the transfer of a
methyl group from S-adenosyl-L-mehionine (SAM) to these groups of polyphenols
having a catechol moiety. Catechol-O-methyl transferase is present in various tissues. Its
activity is highest in the liver and the kidneys (Piskula and Terao, 1998). According to
Manach et al. (2004), another active enzyme in the process of conjugation is
sulfotransferase, which is responsible for sulfation. This enzyme catalyzes the transfer of
sulfate group from 3-phosphoadenosine-5-phosphosulfate to a hydroxyl group on various
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substrates like polyphenols. The third type of conjugation or glucuronidation occurs in
the presence of UDP-glucuronosyltransferase. This enzyme is a membrane-bound
enzyme that is located in the endoplasmic reticulum in many tissues and catalyzes the
transfer of a glucuronic acid from UDP-glucuronic acid to polyphenols. The liver has the
greatest capacity for glucuronidation (Strassburg, 1998, 1999). About 15 isoforms of
UDP-glucuronosyltransferases have been identified in humans. The subfamily of UDPglucuronosyltransferase called UGT1A that is localized in the intestine probably plays a
major role in the first pass metabolism of polyphenols (Manach et al. 2000). Figure 3
(adopted from Scalbert and Williamson, 2000) presents the possible routes of polyphenol
absorption and excretion in humans.
The dose of the ingested polyphenol will determine two important issues: (1) the
primary site of conjugation metabolism; and (2) free or conjugated form of polyphenols
in plasma. Large doses are metabolized primarily in the liver. Small doses may be
metabolized by the intestinal mucosa, with the liver playing a secondary role to further
modify the polyphenol conjugates from the small intestine (Scalbert and Williamson,
2000). For example, in rats, after an oral administration of 10 mg of epicatechin, the
polyphenol was first glucuronidated during intestinal absorption, followed by hepatic
sulfation and methylation, with possible further methylation in the kidneys before
excretion (Piskulaand Terao 1998). The possible routes for ingested polyphenols are
shown in Figure 4 (adopted from Scalbert and Williamson 2000). Saturating or
unsaturating the conjugated metabolic pathway determines the presence of either free
form or conjugated form of polyphenols in plasma. When high doses of polyphenols are
consumed (hundreds of milligrams in one concentrated dose), the conjugated metabolic
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pathway can be easily saturated and the unconjugated form or free form of polyphenols
can be detected in the plasma (Hackett et al. 1983). However, in most cases, polyphenols
derived from food in small doses would not be expected to saturate the metabolic
pathway, and hence the circulating species would be expected to be conjugated.
Generally, polyphenol metabolites do not occur in free form in plasma. Manach et
al. (2004) demonstrated that circulating polyphenols are conjugated derivatives that are
extensively bound to albumin. The affinity of polyphenols for albumin varies according
to their chemical structure. The degree of binding to albumin may have consequences for
the rate of clearance of metabolites and for their delivery to cells and tissues. Polyphenolalbumin complex can dissociate in local pH and lead to free polyphenol ready for
absorption. At physiologic pH, most polyphenols interact with the polar head groups of
phospholipids at the membrane surface via the formation of hydrogen bonds that involve
the hydroxyl groups of the polyphenols (Verstraeten et al. 2003). A high number of
hydroxyl groups on the polyphenol structure and an increase in pH that leads to
deprotonation of the hydroxyl groups would thus enhance interactions between the
polyphenols and the membrane surface, which results in cellular uptake of polyphenols.
According to Manach et al. (2005), gallic acid and isoflavones are the most wellabsorbed polyphenols, followed by catechins, flavanones, and quercetin glucosides, but
with different kinetics. The least well-absorbed polyphenols are the proanthocyanidins,
the galloylated tea catechins, and the anthocyanins. Manach et al. (2005) showed that
those polyphenols such as free hydroxycinnamic acids, gallic acid, and catechin, which
are absorbed in the small intestine, reached their maximum levels in plasma after 1.5
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hour; however, those who were absorbed in the colon after the release of aglycones by
colonic micro flora reached their maximum levels after 5.5 hours.
3. Metabolism by Microflora in Colon
The extensive microflora in the colon also plays a critical role in the metabolism
of polyphenols. Polyphenols that are not absorbed in the stomach or small bowel will be
carried to the colon. In addition, polyphenols that are absorbed, metabolized in the liver
and excreted in the bile or directly from the enterocyte back to the small intestine will also
reach the colon but in a different chemical form, such as a glucuronide (Scalbert and
Williamson, 2000). According to Williamson and Manach (2005), there are two possible
routes available; (1) absorption of intact polyphenol through the colonic epithelium and
passage into the bloodstream (in free or conjugated form); or (2) breakdown of the
original polyphenol structure into metabolites. The colon contains ~10
microorganisms/cm3 and has enormous catalytic and hydrolytic potential. Deconjugation
reactions readily occur (Scalbert and Williamson, 2000). Unlike enzymes in human
tissues, colonic micro flora catalyze the breakdown of the polyphenol itself to more simple
compounds, such as phenolic acids, which could get readily absorbed into the
bloodstream, and then travel to the liver for methylation or conjugation. However, not all
polyphenols are equally susceptible to bacterial degradation, because certain compounds,
such as insoluble tannins, are excreted in feces apparently without being affected by
colonic bacteria.
Additionally, specific active metabolites are produced by the colonic micro flora.
For example, equol produced from soybean daidzein appears to have phytoestrogenic
properties equivalent to or even greater than those of the original isoflavone (Setchell et
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al. 2002). There is great interindividual variability in the capacity to produce equol. Only
30-40% of occidental people excrete significant quantities of equol after consumption of
isoflavones (Lu and Anderson, 1998).
4. Polyphenol Excretion
According to Manach et al. (2004), metabolites of polyphenols may follow two
pathways of excretion, via the biliary or the urinary route. Large, extensively conjugated
metabolites are more likely to be eliminated in the bile, whereas small conjugates such as
monosulfates are preferentially excreted in urine. The major excretion pathway for the
elimination of genistein, epigallocatechin gallate, and eriodictyol is bile (Kohri et al.
2001). Urinary excretion of polyphenols roughly correlated with maximum plasma
concentrations (Manach et al. 2004). Relative urinary excretion is currently used to
estimate the minimal absorption rate but when polyphenols are highly excreted in bile,
absorption is underestimated (Manach et al. 2005). With respect to elimination half-lives,
it appears that catechins, gallic acid, and flavanones do not accumulate in plasma with
repeated ingestion (Manach et al. 2005).
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Figure 3. The possible absorption routes of polyphenols in humans (adopted from
Scalbert and Williamson, 2000)
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Figure 4. The possible routes of ingested polyphenols after absorption in human
body (adopted from Scalbert and Williamson, 2000)
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C. Biological Effects of Polyphenols
Interest in food polyphenols has increased owing to their roles as antioxidants and
scavengers of free radicals. Polyphenol antioxidants function as terminators of free
radicals and chelators of metal ions that are capable of catalyzing lipid peroxidation.
Polyphenols interfere with the oxidation of lipids and other molecules by rapid donation
of hydrogen atom to radicals (Bravo, 1998). The efficiency of polyphenols as
antioxidants greatly depends on their chemical structure. Flavonoids are among the most
potent plant antioxidants because they possess one or more of the structural elements
involved in the anti-radical activity such as the desirable ring structure and optimal
hydroxyl group positions (Manach et al. 1998). Also, the antioxidant efficiency of
flavonoids is directly correlated with their degree of hydroxylation and decreases with the
presence of a sugar moiety (Ratty and Das, 1988). Polyphenols are chelators of metals
and retain their free radial-scavenging capacity after forming complexes with metal ions
(Justesen, Knuthsen and Leth, 1998). It has been shown by Manach et al. (2004) that the
hydrophobicity of polyphenols is intermediate between that of vitamin C (highly
hydrophilic) and that of vitamin E (highly hydrophobic). This theory about antioxidant
activity of polyphenols relates to their water-lipid interface property, which may act in
oxidation regeneration pathways with vitamins C and E.
Traditionally, antioxidant activity was attributed only to soluble polyphenols,
however, recently many reports suggested that insoluble polyphenols such as highmolecular weight hydrolysable tannins and polymeric proanthocyanidins are 15-30 times
more effective at quenching peroxyl radicals than are simple phenols (Hagerman et al.
1998). The main reason behind this fact is that these heavy components are not absorbed,
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so they could exert their antioxidant activity within the digestive tract and protect lipids,
proteins and carbohydrates from oxidative stress during digestion and thus spare soluble
antioxidants (Bravo 1998).
Very little is known about the biological properties of the conjugated derivatives
of polyphenols present in plasma or tissues because of the lack of precise identification
and commercial standards for the needed assays (Manach et al. 2004). In fact, conflicting
data have been reported about antioxidant activity of conjugated and deconjugated
polyphenols. Several in vitro studies showed that the antioxidant effect of conjugated
derivatives of quercetin on copper ion-induced LDL oxidation in vitro is about one-half
that of the aglycone (Manach et al. 1998, Day et al. 2000). Cren-olive et al. (2003)
showed that methylation of catechin reduces its ability to inhibit LDL oxidation.
However, according to in vivo studies, which reported an increase in the antioxidant
capacity of plasma after the consumption of various polyphenol rich foods, at least some
of the polyphenol metabolites retain antioxidant activity (Rein et al. 2000, Whitehead et
al. 1995, Cao et al. 1998). It is still difficult to draw any conclusions from the few
existing studies regarding the antioxidant capacity of polyphenol derivatives.
Antioxidants polyphenols are potent inhibitors of LDL oxidation in vitro (Frankel
et al., 1993). In vivo studies showed reduced susceptibility to LDL oxidation in subjects
supplemented with red wine or red wine polyphenols (Fuhrman et al., 1995; Nigdikar et
al., 1998). Thus, polyphenols probably protect LDL oxidation in vivo with significant
consequences in atherosclerosis, and also protect DNA from oxidative damage with
important consequences in the age-related development of some cancers (Halliwell,
1999).
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Several mechanisms have been suggested by Cook and Samman (1994) by which
polyphenols, in particular flavonoids exert their protective effects; (1) radical and oxidant
scavenging; (2) protection of oc-tocopherol in LDL from oxidation; (3) regeneration of
oxidized a-tocopherol; and (4) chelation of metal ions. Through these antioxidant
actions, polyphenols exert their protective effect against cardiovascular disease. In
addition, Pietta (2000) showed that absorbed flavonoids and their metabolites may
display in vivo antioxidant activity by a mechanism which might be different from what
has been reported previously. He showed that absorbed flavonoids have a sparing effect
on a-tocopherol and (3-carotene concentrations.
Radical and oxidant scavenging property of polyhenols have been studied and
various mechanisms have been proposed to explain those observations. For example, Frei
and Higdon (2003) showed that the ability of a compound to act as a free radical
scavenger is partly related to its standard one-electron reduction potential (E°), a measure
of the reactivity of an antioxidant as hydrogen and electron donor under standardized
conditions. A lower E° indicates that less energy is required for hydrogen or electron
donation and is one factor in determining antioxidant activity. It is well-known that free
radicals cause autoxidation of unsaturated lipids in food (Sherwin, 1978). The
antioxidants intercept the free radical chain oxidation by donating hydrogen from the
phenolic hydroxyl groups, thereby forming a stable end product which does not initiate or
propagate further oxidation of lipids (Kubow, 1993). In addition to antioxidant property
of polyphenols, flavonoids have anti-thrombotic and anti-inflammatory effects (Gerritsen
et al. 1995; Muldoon and Kritchevsky, 1996). The antimicrobial property of polyphenolic
compounds has been well documented (Chung et al., 1998).
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Several types of polyphenols (phenolic acids, hydrolysable tannins, and
flavonoids) show anti-carcinogenic and anti-mutagenic effects. Polyphenols might
interfere in several of the steps that lead to the development of malignant tumors,
inactivating carcinogens, inhibiting the expression of mutant genes and the activity of
enzymes involved in the activation of procarcinogens and activating enzymatic systems
involved in the detoxification of xenobiotics (Bravo, 1998).
Several studies have shown that in addition to their antioxidant protective effect
on DNA and gene expression, polyphenols, particularly flavonoids, inhibit the initiation,
promotion, and progression of tumors, possibly by a different mechanism. Wine contains
many compounds that apparently exhibit anti-cancer properties, including gallic acid,
caffeic acid, ferulic acid, catechin, quercetin and resveratrol, among others. In an
experiment with transgenic mice that spontaneously developed skin tumors, the addition
of red wine solid extract to their diet led to a marked delay in tumor development
(Clifford et al., 1999). Caffeic and ferulic acids react with nitrite in vitro and inhibit
nitrosamine formation in vivo (Kaul and Khanduja, 1998).
D. Polyphenol Content of Foods
The main food sources of polyphenols are fruits and vegetables. Most of the
polyphenols are specific to particular foods such as flavanones in citrus fruit, isoflavones
in soybeans, and phloridzin in apples, but a few polyphenols like quercetin can be found
in almost all fruits, vegetables, legumes, wine, and tea. The polyphenol composition of
foods is varied; for example, apples have a combination of epicatechin, procyanidin,
hydroxyl cinnamic acid, and anthocyanin (Manach et al. 2004). Tea contains catechin,
epicathechin, epicatechigallate, epigallocatechin and epigallocatechin gallate (EGCG).
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EGCG makes up about 40% of the total catechin content and is widely accepted as the
major antioxidant ingredient in green tea and green tea extract (Seeram et al. 2006).
Fermentation of black teas actually consists of enzymatic oxidation of native green tea
polyphenols, catalyzed by polyphenols oxidase, followed by chemical reactions of the
resulting quinines (Belantine et al. 1997). A major part of tea leaf flavanols are thus
converted into various types of products, including thearubigins and theaflavins, which
are responsible for the characteristic dark brown color of black tea (Roberts, 1958).
Table 1 presents the polyphenol content of a typical serving of commonly
consumed fruits and vegetables (Wu et al. 2004) measured by Folin-Ciocalteau reagent.
This method is based on polyphenols reducing capacity relative to an equivalent reducing
capacity of gallic acid or standard (Frankel et al. 1995). Information about complete
polyphenol composition in a variety of fruits and vegetables is very limited and requires
further investigation.
Many different factors may influence the polyphenol content of food. These
factors are (1) environmental; (2) storage; (3) cooking and culinary; and (4) food
processing. Environmental factors have a major effect on the polyphenol content of food.
According to Manach et al. (2004), the environmental factors could be pedoclimatic (soil
type, sun exposure, rainfall) or agronomic (culture in greenhouses or fields, biological
culture, hydroponic culture, fruit yield per tree, etc). Macheix, Fleuriet & Billot (1990)
reported that the degree of ripeness can directly affect the proportions of various
polyphenols in fruits. For example, phenolic acid concentrations decrease during
ripening, whereas anthocyanin concentrations increase.

27

Table 1. Polyphenol content of a typical serving of commonly consumed fruits and
vegetables1 (Wu et al. 2004)
Food name

Variety

Total polyphenols (mg GAE/g)

Serving size (g)2

Fuji
Gala

2.11 ±0.32
2.62 ± 0.29
1.33
1.87 ±0.23
2.31 ±0.60
6.60 ±2.85
3.68 ± 0.80
5.04 ±0.84
3.66 ± 1.09
1.74 ±0.52
2.66
2.78 ±0.39

138
138
105
173
118
144
166
123
66
155
165
76

Green
Red

1.45 ±0.11
1.75 ±0.17
2.14 ±0.33
0.72 ±0.34
3.37 ±0.39
0.59 ±0.14
1.92 ±0.33

160
160
123
170
140
152

0.91 ±0.09
1.26
3.66
0.56 ±0.21
1.56 ±0.28

80
80

Apple

Apricot
Avocado
Banana
Blackberry
Strawberry
Raspberry
Plum
Pineapple
Mango
Kiwi
Grape

Grapefruit
Honeydew
Orange
Watermelon
Tangerine
Onion
Yellow
Red
Broccoli
Celery
Carrot
Cauliflower
Tomato
Spinach
Radish
Beet
Artichoke
Potato

2.74

1.00±0.11
2.17
1.10 ±0.28

Red
Russet
White

84

85
60
46
50
120
40

2.44

116
68

7.92

84

1.76 ±0.16
1.79 ±0.57
1.63 ±0.17

173
299
213

Data expressed on the "as is" weight basis and presented as mean ± SD for sample numbers
Serving size from the USD A National Nutrient Database for Standard Reference
(www.nal.usda.gov/fhic/foodcompl.

2
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Table 2. Polyphenol content of a typical serving of commonly consumed spices1 (Wu
et al. 2004)
Total polyphenols (mg GAE/g)

Food name

44.89
17.13
157.18
113.19
10.75

Basil leaf, dried
Chili powder
Cinnamon, ground
Cloves, ground
Curry powder
Garlic powder
Ginger, ground
Mustard seed, yellow, ground
Onion powder
Oregano leaf, dried
Paprika
Parsley, dried
Pepper, black, ground
Pepper, black, whole peppercorn
Poppy seed
Turmeric

0.42

3.17
18.44
8.61
72.82
18.66
22.44
3.83

7.11
0.20

21.17

Data expressed on the "as is" weight basis and presented as mean ± SD for sample numbers

Storage may also influence the content of polyphenols that are prone to oxidation.
As stated by Manach et al. (2004), oxidation reactions result in the formation of more or
less polymerized substances, which lead to changes in the quality of foods, particularly in
color and organoleptic characteristics. Such changes maybe beneficial (as is the case with
black tea) or harmful (browning of fruit) to consumer acceptability. Storage of wheat
flour results in marked loss of phenolic acids (Sosulski, Krygier & Hogge, 1982).
Different methods of culinary preparation have a noticeable effect on the
polyphenol content of foods. Often polyphenols are present in the outer layer of fruits, so
peeling can remove a significant portion of these substances. Cooking may also have a
major effect. Crozier et al. (1997) showed the significant effect of cooking on
polyphenols present in onions and tomatoes. They demonstrated that onions and tomatoes
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lose between 75% and 80% of their initial quercetin content after boiling for 15 minutes,
65% after cooking in a microwave oven, and 30% after frying.
Industrial food processing contains many different techniques that certainly affect
polyphenol content of foods. Some of these techniques are fruit peeling, dehulling of
legume seeds, decortication and bolting of cereals, grinding, clarification, or stabilization
in fruit jam production, etc.
F. Polyphenol Content of Nuts
Nuts are an important source of dietary lipids and have been suggested as a
potential source of dietary antioxidants on the bases of epidemiological and cohort
studies (Fraser et al .1992, Hu et al. 1998, and Kris-Etherton, 2001). Total polyphenols
content of different nuts as reported from Wu et al. (2004) is shown in Table 3.
Table 3. Total polyphenols content of one ounce (28.4 g) nuts i
Nut

T
2

Total Polyphenol (mg of GAE/ g)2

Almonds

4.18 ±0.84

Brazil nuts
Cashews
Hazelnuts
Macadamias
Peanuts
Pecans
Pine nuts
Pistachios
Walnuts

3.10 ±0.96
2.74 ± 0.39
8.35 ±2.16
1.56 ±0.29
3.96 ±0.54
20.16 ± 1.03
0.68 ± 0.25
16.57 ± 1.21
15.56 ±4.06

Serving size from USDA National Nutrient Database for Standard Reference
Total polyphenols data expressed as milligrams of gallic acid equivalents per gram (mg of
GAE/g)

1. Polyphenol Content of Walnuts
Walnuts are unique among the edible tree nuts because of their relatively high
content of polyunsaturated fatty acids. These fatty acids are prone to oxidation and thus,
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it is of interest that the pellicle surrounding the kernel is naturally rich in antioxidant
polyphenols, in addition to the high content of tocopherols in the kernel itself (Lavedrine,
Ravel, Poupard, & Alary, 1997 and Fraser, 1999). Walnut pellicles contain a number of
non-flavonoid phenolics. Based on early work using liquid and paper chromatography
(Jurd, 1958), at least 10 polyphenols have been reported to be present in English walnut
pellicle extract. These polyphenols include the monomers ellagic acid, gallic acid, and
methyl gallate, which when present as polymers and bound to sugars are known as
hydrolyzable tannins, and comprise the majority of the polyphenols present (Jurd, 1956,
1957 & 1958). Recently, Colaric et al (2005) identified chlorogenic acid, caffeic acid,pcoumaric acid, ferulic acid, and sinapic acid (hydroxycinnamic acids), ellagic acid,
syringic acid (hydroxybenzoic acids) as well as syringaldehyde (a hydroxybenzoic
aldehyde) and juglone (a quinone) in the walnut kernel and pellicle. Colaric (2005) has
reported that walnut kernels contained syringic, caffeic, ferulic, vanillic, gallic,
protocatechuic, and phenylacetic acid in very small quantities ranging from 2 to 20 f*
g/100 g of kernels. Cultivar variations in phenolics contents were observed in Colaric
study (2005). Extracts of walnuts and other nuts have been tested for total antioxidant
activity in vitro by HPLC method (Anderson et al. 2001; Halvorsen, Holte & Myhrstad,
2002). The extract from 50 gram walnuts and pecans, contained an activity of 802mg
and 500mg gallic acid equivalent (GAE), respectively (Senter, Horvat, & Forbus, 1980).
Walnuts have favorable levels of total phenols relative to other foods reported to have
high phenolic and antioxidant levels, when compared on a per serving basis (Anderson et
al. 2001). A handful of walnuts (50g) has significantly more phenolics than an 8oz glass
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of apple juice (Pearson, 1999), and a 5oz glass of red wine (Frankel, Waterhouse &
Teissedre, 1995).
2. Polyphenol Content of Almonds
Almonds are an attractive subject for polyphenol study due to their widespread
consumption and increasing popularity. Although published information on almond
flavonoid composition is scarce, the presence of certain polyphenols has been confirmed.
Several studies report procyanidins of varying degrees of polymerization occurring in the
almond seed coat, almond flesh, and almond fruit (Plumb et al. 1998, Lazarus et al.
1999). Sang et al. (2002) found one new prenylated benzoic acid derivative, 3-pemyl-4O-p-D-glucopyranosyloxy-4-hydroxylbenzoic acid, and three known constituents,
catechin, protocatechuic acid, and ursolic acid in almond hulls. In another research study
conducted by Sang and his coworkers, they identified nine polyphenol compounds, which
were isolated from the ethyl acetate and n-butanol fractions of almond skins. These nine
compounds were (1) 3'-0-methylquercetin 3-O-P-D-glucopyranoside, (2) 3'-0Methylquercetin 3-O-P-D-galactopyranoside, (3) 3'-0-methylquercetin 3-O-ot-Lrhamnopyranosyl-(l-»6)-P -D-glucopyranoside, (4) kaempferol 3-O-a-Lrhamnopyranosyl-(l-*6)-P -D-glucopyranoside, (5) naringenin 7-O-P-D-glucopyranoside,
(6) catechin, (7) protocatechuic acid, (8) vanillic acid and (9) p-hydroxybenzoic acid.
These were divided into flavonoids and phenolic acids. Catechin is the flavonoid found in
almonds that is the most widely distributed in edible plants, which shows high
antioxidant property. According to Sang et al. (2002), eight out of nine recognized
polyphenol compounds in almond skin, showed strong radical scavenging activity.
Moreover, Frison-Norrie and Spoms (2002) have identified four flavonol glycosides in
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almond seed coats: isorhamnetin rutinoside, isorhamnetin glucoside, kaempferol
rutinoside, and kaempferol glucoside. In addition to polyphenols in almonds, three
different triterpenoids, betulinic acid, oleanolic acid and ursolic acid were extracted from
almond hulls by Takeoka et al. (2000). These three components have anti-inflammatory
(Singh and Roberts, 1994), anti-HIV (Kashiwada et al. 1998) and anti-cancer properties.
F. Analytical Procedures
Polyphenols are abundant micronutrients in our diet, and evidence for their role in
the prevention of degenerative diseases such as cancer and cardiovascular disease is
emerging (Manach et al. 2004). The health effects of polyphenols depend on the amount
consumed and most importantly the amount which is absorbed. To determine whether
polyphenols are absorbed following the consumption of food, two different types of
studies were conducted based on direct and indirect evidences of bioavailability of
polyphenols. Direct evidence of bioavailability can be obtained from plasma
concentration of individual polyphenols or total polyphenols in plasma, which was
measured by Folin-Ciocalteau (FC) assay. Indirect evidence can be gained from
employing assays such as plasma antioxidant capacity and lipid peroxidation
susceptibility after the ingestion of selected foods. Plasma antioxidant status is a result of
the interaction of many different in vivo metabolic systems with dietary antioxidant
components. Several methods have been developed for measuring total antioxidant
capacity of blood, and the most commonly used ones are as follows; (1) ferric ion
reducing antioxidant power assay (FRAP); (2) oxygen radical absorbance capacity
(ORAC); and (3) trolox equivalent antioxidant capacity (TEAC) Assay. For measuring
lipid peroxidation, the thiobarbituric reactive substances (TEARS) assay is generally
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employed. Mechanistically, these methods are based on either a single electron transfer
reaction or a hydrogen atom transfer reaction between an oxidant and a free radical. For
single electron transfer based methods, such as the FRAP and TEAC assay, antioxidants
are oxidized by the oxidants., Fe (III) and ABTS+*, respectively. As a result, a single
electron is transferred from the antioxidant molecule to the oxidant. The change of
absorbance of either the antioxidant or oxidant is measured by ultraviolet-visible
spectrometer and the absorbance value is used as the quantitation for the reducing
capability of the antioxidant (Ou et al. 2002). The hydrogen atom transfer based method,
such as ORAC, utilizes a radical initiator to generate peroxyl radical ROO*. The ROO*
abstracts a hydrogen atom from antioxidant. As a result, the reaction between ROO* and
the target molecule probe is retarded or inhibited.
1. Assays
Total Phenol Assay by the Folin-Ciocalteau (FC) Reagent
Due to the difficulty in measuring each polyphenol component separately and
interactions among methods, we measured the total polyphenol content of plasma after
ingestion of polyphenol rich food by using Folin-Ciocalteau reagent. This method was
first applied to measure polyphenols in food extracts, then recently adapted to plasma by
Serafini et al. in 1998. Serafini et al. precipitated plasma protein first, and then
supernatant was extracted in order to measure polyphenols by using FC reagent. This
method does not actually measure the amounts of polyphenol compounds in the blood,
but is in fact based on polyphenols reducing capacity relative to an equivalent reducing
capacity of gallic acid as standard (Frankel et al. 1995).
Ferric Ion Reducing Antioxidant Power Assay (FRAP) Assay
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This method measures the ferric reducing ability of plasma. At low pH, when the
ferric tripyridyltriazine (Fe III-TPTZ) complex is reduced to the ferrous (Fe II) form, an
intense blue color with an absorption maximum at 593 nm develops (Benzie, 1996). Test
conditions favor reduction of the complex and thereby color development, provided that a
reductant (antioxidant) is present. Absorbance changes are linear over a wide
concentration range with antioxidant mixtures, including plasma and with solutions
containing antioxidants.
Oxygen Radical Absorbance Capacity (ORAC) Assay
The ORAC method with fluorescein as fluorescent probe was used as described
by Prior et al. (2003). The method involves extraction and analysis of hydrophilic and
lipophilic antioxidants in plasma. The ORAC method is based on the inhibition of the
peroxyl-radical-induced oxidation initiated by thermal decomposition of azo-compounds
like 2,2'-azobis (2-amidino-propane) dihydrochloride (AAPH). Under appropriate
condition, the loss of fluorescein in the presence of reactive oxygen species is an index of
oxidative damage. The inhibition by an antioxidant, which is reflected in protection
against the loss of fluorescein in the ORAC assay, is a measure of its antioxidant capacity
(O’Byrne et al. 2002). This assay utilizes a biological relevant radical source and is the
only method that combines both inhibition time and degree of inhibition into a simple
quantity.
Trolox Equivalent Antioxidant Capacity (TEAC) Assay
According to Re et al. (1999), this is a decolorization assay, applicable to both
hydrophilic and lipophilic antioxidants. The pre-formed radical monocation of 2,2'azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS+*) is generated by oxidation of
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ABTS with potassium persulfate and is reduced in the presence of such hydrogendonating antioxidants. The influences of both the concentration of antioxidant and
duration of reaction on the inhibition of the radical cation absorption are taken into
account when determining the antioxidant activity.
Thiobarbituric Reactive Substances (TEARS) Assay
TEARS is a method used for investigating lipid peroxidation products.
Assessment of TEARS is commonly used to measure plasma and tissue concentration of
malondialdehyde (MDA), a decomposition product of oxidized lipids, and as an index of
plasma and tissue lipid peroxidation. MDA forms a 1:2 adduct with thiobarbituric acid,
which can be measured by spectrophotometry. Biological specimens contain a mixture of
thiobarbituric reactive substances, including lipid hydroperoxides and aldehydes, which
increase as a result of oxidative stress. However, the utility of the TEARS assay as a
measure of lipid peroxidation in vivo is questionable due to its lack of specificity for
MDA in biological samples and its susceptibility to artifactual ex vivo oxidation (Frei
and Higdon, 2003).
2. Review of Postprandial Studies and the Effect of Foods on Plasma Polyphenols
Several studies have been demonstrated an increase of plasma total polyphenols
after the ingestion of various fruits, vegetables, coffee, tea, chocolate and wine. The first
study on the vivo effect of a polyphenol-rich beverages was published in 1994 by Serafini
et al. and Maxwell et al. which showed a significant increase in plasma total polyphenols
after consumption of tea and wine. Whitehead et al (1995) confirmed that the
consumption of moderate amounts of red wine elicits a prompt though temporary rise of
plasma anti-oxidant defenses. Serafmi et al. in 1996, compared green and black tea and
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found that both green and black tea represent an excellent source of antioxidant
polyphenols, green tea being about five times more potent than black tea. They indicated
that a high concentration of simple hydroxyl groups to be directly related to the
antioxidant property of tea. They also established that the bolus ingestion of one cup of
tea produces an appreciable increase in plasma FRAP. A study of tea consumption
conducted by Langley-Evans (2000) used FRAP assay and showed that high levels of
habitual tea intake (six or more cups a day) are sufficient to increase circulating
antioxidant potential. Van het Hof et al. (1999) have demonstrated that tea catechins from
both green and black teas appear in human plasma and in the circulating lipoprotein
fractions. Five cups of tea consumed at two hour intervals was sufficient to elevate
plasma catechin concentrations up to 12-fold. This effect is abolished through the
addition of milk to tea. In this study, Langley-Evans reported an increase in FRAP values
after the consumption of black tea without milk. The study showed that plasma
polyphenol concentration reaches a plateau after three to four cups of tea and
continuation of tea consumption appears to sustain the response. In regards to the
metabolic fate of tea, Mulder et al. (2005) conducted a study showing excretion of
hippuric acid, a major metabolite produced from tea catechin, into urine. Mulder and his
co-workers showed a massive increase in urinary hippuric acid excretion after black tea
consumption. These results provide an estimate amount of phenolic metabolites formed
by the micro flora and excreted in the urine of human subjects after consumption of tea.
The three forms of polyphenol in tea are catechin, theaflavin and thearubigin, which
significantly increase plasma total polyphenol levels. The first two are metabolized in the
small intestine and the last one is metabolized in the colon and is reabsorbed.
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Another polyphenol-rich beverage is wine, which has captured the attention of
many different scientists. The effect of wine and whisky was investigated by Duthie et al
in 1998. They found that consumption of phenolic-containing alcoholic beverages
transiently raises total polyphenol concentrations and enhances the antioxidant capacity
of plasma. A significant increase in plasma total polyphenol was detected within 30
minutes of consumption of wine and whisky, which was maintained for the duration of
five hours.
The non-alcoholic component of wine has been studied as well. Serafmi, Maiani
and Ferro-Luzzi (1998) sought to determine whether the non-alcoholic component of
wine increases plasma antioxidant capacity and whether such an effect is associated with
the presence of polyphenol compounds in plasma. The result of this study indicated that
the ingestion of alcohol-free red wine caused a significant increases in plasma FRAP
values and in polyphenol concentrations at around 50 minutes after ingestion. The
achievement of peak plasma concentration 50 minutes after ingestion of non-alcoholic
red wine suggests that the absorption of polyphenols might occur, under the fasting
conditions, mainly in the gastroduodenal region and in lesser amounts in the jejunum. A
comparison study between alcoholic red wine and non-alcoholic red wine conducted by
Donovan et al. (1999) showed that polyphenol or catechin and its metabolites were
present almost exclusively in plasma at every time point after ingestion of both beverages
independent of ethanol.
Furhman et al. (1995) compared red and white wine and surprisingly found that
daily consumption of red wine (400ml) for two weeks reduced susceptibility of LDL to
oxidation, which was associated with an increase in total polyphenol levels in plasma,
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whereas white wine showed the opposite effect. White wine contains only a minimal
amount of polyphenols compared with red wine. This may undermine the ability of
white wine to act as an antioxidant (Frankel et al. 1995). In a study by Carbonneau et al.
(1997), dietary supplementation with an extract of phenolic compounds from red wine to
subjects for two weeks increased antioxidant capacity of plasma but had no effect on
isolated LDL oxidation. Nigdikar et al. (1998) observed a prolonged lag time to copper
catalyzed oxidation of LDL after subjects consumed red wine for two weeks. They
suggested that the difference in the outcome of red wine’s effect on LDL oxidation may
have been due to differences in methodology.
Another food source which is known to be rich in polyphenols is chocolate and
cocoa. To begin to investigate the presence or absence of polyphenols in chocolate,
various studies were conducted. For example, in a study conducted by Wang et al. (2000)
on chocolate, a dose-response effect of chocolate consumption on plasma polyphenols
was observed. They found a linear relationship between the amount of consumed
chocolate and plasma polyphenol concentrations. The highest plasma epicatechin
concentration was seen two hours after the consumption of 80g of chocolate. This rise of
plasma epicatechin levels was functionally more significant in higher doses of chocolate
compared to the lower doses, and contributes to the ability of plasma to scavenge free
radicals and inhibits lipid peroxidation. Rein et al. (2000) determined the physiological
levels of epicatechin, catechin and epicatechin dimers derived from chocolate. They
found that two hours after the ingestion of 80g of semi-sweet chocolate, there was a 12
fold increase in plasma epicatechin from 22 to 257 nmol/L. Consistent with the
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antioxidant properties of epicatechin, within the same two hour period, there was a
significant increase of 31% in plasma total antioxidant capacity.
A recent study in 2004 conducted by Seeram, Lee and Heber on bioavailability of
ellagic acid in human plasma after consumption of pomegranate juice showed that ellagic
acid was detected and quantified in human plasma and samples collected at 0.5 h (20.5
ng/ml), 1 h (31.9 ng/ml), 2 h (22.4 ng/ml) and 3 h (16.2 ng/ml) post-ingestion and was
not detected in plasma samples collected at 4 and 6 h after consumption. The maximum
was found to be after 1 h post-ingestion.
One of the other beneficial effects of polyphenols, which has been recently
investigated, is the inhibitory effects of polyphenols in berries on digestive enzymes. This
study was conducted by McDougall and Stewart (2005), which showed anthocyanins
inhibit alpha-glucosidase activity and can reduce blood glucose levels after starch-rich
meals, a proven clinical therapy for controlling type II diabetes. They also reported that
ellagitannins inhibit alpha-amylase activity and there is potential for synergistic effects
on starch degradation after ingestion of berries such as raspberries and strawberries,
which contain substantial amounts of ellagitannins and anthocyanins.
G. Conclusion
In summary, although several in vitro and in vivo studies have been conducted on
variety of polyphenol-rich foods, no in vivo study has been performed on nuts in
particular. Plasma polyphenol levels, plasma antioxidant concentrations, and inhibition of
lipid peroxidation should be investigated in nuts.
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CHAPTER 3
METHODS
A. Subjects
Healthy, nonsmoking men and women aged 19-65 y were recruited from Loma
Linda University students, faculty and staff by using advertisement flyers around the
campus, cafeteria, medical center, etc. The screening was done by nutrition students in
the form of person-to-person interviews. Subjects were eligible if they met the following
inclusion criteria: (i) apparently healthy as indicated by a general medical questionnaire,
(ii) body mass index (BMI) <30 kg/m ; (iii) not allergic or sensitive to nuts; (iv) not
pregnant or lactating; and (v) not taking any dietary supplements. Sample size was
calculated for a three treatment, three period crossover design using SAS version 8.0
(SAS software, 1999), based on the method recommended in Senn (1993). The sample
size calculation was based on an estimate of the SD of the treatment difference (the
difference between treatment and control measurements of plasma phenols taken on an
individual) of 2.5 mg/L obtained from similar research (O'Byme et al. 2002). At the .05
level of significance, a sample size of six subjects will provide >90% power to detect a
15 mg/L change in plasma phenol concentration. However, 14 subjects were recruited to
the study, allowing six people for drop-outs. Therefore, 14 healthy volunteers (seven
women and seven men) were enrolled at the beginning, but one person decided not to
continue after the first clinic visit, so the study was conducted and completed on 13
healthy individuals. The study was approved according to the principles of Institutional
Review Board (IRB) office of Loma Linda University. All participants in this study gave
their informed consent.
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B. Study Design
The acute (postprandial) response to a challenge meal containing nuts on
antioxidant markers in plasma was assessed and compared using a Latin-square design.
After an overnight fast, walnut, almond, and a control meal in the form of smoothies were
consumed by study subjects. Each subject participated on three occasions one week apart,
consuming one of the smoothies each time. Subjects were randomly assigned to one of
the six following treatment sequences.
1. Almond, Walnut, Control
2. Almond, Control, Walnut
3. Walnut, Control, Almond
4. Walnut, Almond, Control
5. Control, Almond, Walnut
6. Control, Walnut, Almond
The study was designed so that each individual becomes his/her own control by
undergoing treatment and control diets. Each clinic visit was held on a weekday starting
from 8:00 a.m. to 12:00 p.m. Participants came to the clinic after a 12-hour fast and a
trained phlebotomist used a catheter to collect a baseline blood sample. Participants were
then provided with either a nut-containing smoothie or a nut-free smoothie for breakfast.
Nut smoothies contained 75% (2-4 oz) walnut or almond. Additional blood samples were
collected 30, 90, 150, and 210 minutes after breakfast. A total amount of 50 ml equal to
3.75 tablespoon blood was drawn. During the test participants were allowed to drink only
water and remain sedentary. Participants were required not to eat any kind of nut, fruit,
vegetable, chocolate (any cocoa containing product), and not to drink coffee (regular or
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decaf), tea (black or green), juice (fruit or vegetable) and wine (red or white) 24 hours
prior to the clinic session.
C. Test Meals
For the nut-containing meals, nuts provided 75% of total energy intake
(approximately 10 kcal per kilogram body weight) and the remaining 25% of energy
come from a carbohydrate source. For the control meal, macronutrient composition
similar to nut-containing meals was calculated and following food sources were used: (1)
carbohydrate as polycose; (2) fat as whipping cream and coconut oil; and (3) protein as
purified whey protein (Pro Mod Powder, Abbott Laboratories, Columbus, OK). The
meals were blended and presented as a shake or smoothie. Composition of the three
meals (walnut, almond and control) is presented in Appendix 1.
D. Collection of Plasma Samples
Blood was drawn into vacutainer tubes containing EDTA or sodium heparin.
Because blood samples needed to be collected at different times, an indwelling catheter
was inserted in a vein of the forearm by a trained phlebotomist the first thing in the
morning of the clinic session. Additional blood samples were then drawn from the
catheter at appropriate times throughout the day. A total of 50 ml blood was drawn each
session. Plasma was prepared by centrifugation (1500 x g for 10 min at 4°C) and frozen
immediately and stored at -80°C until analysis.
E. Determination of Plasma Polyphenols by the Folin-Ciocalteau (FC) Assay
It is possible to obtain an estimate of total phenolic and polyphenolic content of
diets and of the plasma by using the Folin-Ciocalteau colorimetric assay. This method
was originally introduced in 1912 and was extensively upgraded and improved by
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Professor Vernon Singleton of UC Davis during the 1970's, 80's and 90’s. We used the
method as modified by Serafmi et al in 1998 to remove protein interferences. The
principle of this method is the FC-Reagent, which is a solution of complex polymeric
ions formed from phosphomolybdic and phosphotungstic heteropoly acids, oxidises
phenolates, reducing the heteropoly acids to a blue Mo-W complex. The phenolates are
only present in alkaline solution but the reagent and products are alkali unstable, hence a
moderate alkalinity and a high reagent concentration are used in the procedure. Total
phenolic concentrations of plasma samples were determined after a procedure of acid
extraction/hydrolysis, and protein precipitation with 0.75 mol/L metaphosphoric acid
(MPA). For hydrolyzing the conjugated forms of polyphenols, hydrochloride acid (HC1)
was added to the sample, followed by sodium hydroxide (NaOH) in methanol. This step
breaks the links of polyphenols with lipids and provides a first extraction of polyphenols.
For removing plasma proteins MPA was in this procedure. The final extraction of
polyphenols was done by adding 1:1 (v/v) solution of acetone:water. The results were
expressed as milligrams gallic acid equivalent (GAE) per liter. The FC assay procedure is
described in detail in appendix 1.
F. Antioxidant Capacity Analyses
The following methods were applied to measure the antioxidant capacity of
plasma: the ferric reducing ability of plasma (FRAP) assay as described by Benzie and
Strain (1996); the Trolox equivalent antioxidant capacity (TEAC) assay of Miller and
Rice-Evans (1993); and the oxygen radical absorbance capacity (ORAC) developed by
Cao and Prior (1999) and recently modified by Prior et al. (2003).

44

1. Ferric Ion Reducing Antioxidant Power (FRAP) Assay
This method measures the ferric reducing ability of plasma, which takes
advantage of electron-transfer reactions. At low pH, when a ferric tnpyridyltnazme (Fe TPTZ) complex is reduced to ferrous (Fe2+) form, an intense blue color with an
absorption maximum at 593 nm develops. The reaction is non-specific, and any halfreaction which has a less positive redox potential, under reaction conditions, than the Fe 3+
/ Fe2+ -TPTZ will drive Fe3+-TPTZ reduction. Test conditions favor reduction of the
complex and thereby color development, provided that an antioxidant is present. The
FRAP assay is quick and simple to perform, and the reaction is reproducible and linearly
related to the molar concentration of the antioxidant(s) present. The FRAP assay was
adopted from Benzie and Strain (1996). The FRAP assay involves a detailed procedure
shown in appendix 2.
The oxidant in the FRAP assay is prepared by mixing TPTZ with acetate buffer,
and FeCl3-H20. The cocktail is referred to as "FRAP reagent." The final solution has
Fe(III) of 1.67 mM and TPTZ of 0.83 mM. Therefore, the TPTZ is deficient as the ideal
reaction stoichiometry between Fe(III) and TPTZ is 1 to 2. The oxidant is not just
Fe(III)(TPTZ)2, it also contains other Fe(III) species which can lead to potential problems
as many metal chelators in food extract could bind Fe(III) and form complexes that are
also capable of reacting with antioxidants. To measure FRAP value, freshly prepared
FRAP reagent should be used. Absorbance readings are taken after 0.5 s and every 15 s
for four minutes. The change of absorbance (AA = ri4mjn - riomin) is calculated and related
to A A of an Fe(II) standard solution. AA is linearly proportional to the concentration of
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antioxidant. One FRAP unit is arbitrarily defined as the reduction of 1 mol of Fe(III) to
Fe(II).
2. Oxygen Radical Absorbance Capacity (ORAC) Assay
The ORAC assay depends on the free radical damage to a fluorescent probe
through the change in its fluorescence intensity. The change of fluorescence intensity is
an index of the degree of free radical damage. In the presence of antioxidant, the
inhibition of free radical damage by an antioxidant, which is reflected in the protection
against the change of probe fluorescence in the ORAC assay, is a measure of its
antioxidant capacity against the free radical. This assay utilizes a biological relevant
radical source and is the only method that combines both inhibition time and degree of
inhibition into simple quantity.
(Coaet al. 1998).
Plasma Extraction. Plasma or serum samples that had been stored at -80° C were
thawed slowly, mixed well on a vortex, and centrifuged if needed. Plasma or serum
extraction was based upon the procedure published by Aebischer et al. (1999). One
hundred iLL of plasma or serum was transferred to a glass tube, 200 AL of ethanol and 100
of water was added and mixed, and then 400

of hexane was added, followed by

mixing. The mixture was left to sit for one to two minutes or until two layers appeared,
followed by centrifugation for fives minutes at 14 000 rpm. The hexane layer was
removed and added to a separate amber tube. An additional 400

of hexane was added

to the original tube, mixed, left to settle for two minutes, and then centrifuged for five
minutes at 14 000 rpm. The hexane layer was removed and combined with the first
extract. The combined hexane extracts were dried down under nitrogen flow in

46

preparation for lipophilic ORACfl analysis. Any hexane remaining following hexane
extraction of the aqueous plasma sample was removed by drying under nitrogen. Then
400

of 0.5 M perchloric acid was added to precipitate the protein. The sample was

then centrifuged for five minutes at 14 000 rpm. From the supernatant, 160 flL was added
to 840

of phosphate buffer and mixed.
Lipophilic ORACfl Assay (ORAC upo). For the lipophilic antioxidant assay, the

dried hexane extract was dissolved in 250

of acetone and then diluted with 750 /AL of

a 7% randomly methylated beta-cyclodextrin (RMCD) solution (50% acetone/50% water,
v/v). RMCD is a water solubility enhancer for lipophilic antioxidants. Any further
dilution was with the 7% RMCD solution. The 7% RMCD solution was used as a blank
and to dissolve the Trolox standards for the lipophilic assay. For plasma lipophilic
analysis, 40

of this solution was added to the 48 well microplate. Four hundred

of

fluorescein solution was added by injectors in the microplate reader, followed by 150 iLL
of AAPH (17.2 mg/mL, 9.4 ^mol/well); readings were initiated immediately.
Hydrophilic ORACfl Assay (ORAChydro)- Any further dilution of the hydrophilic
fraction (acetone/water/acetic acid extract) was made with phosphate buffer. A 40-fAL
portion of the diluted sample was added to a well in a 48 well microplate. The fluorescein
solution and AAPH were added in the same manner as that for the lipophilic assay,
except that only 75 fAL of the AAPH was added to the assay mixture.
Area under the Curve (AUC). The final ORACfl values were calculated by using a
quadratic regression equation (y = ax2 + bx + c) between the Trolox or sample
concentration and net area under the fluorescein (FL) decay curve. Data are expressed as
micromoles of Trolox equivalents (TE) per gram or per milliliter of sample (mol of
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TE/g or ^mol of TE/mL). The area under the curve was calculated according to this
equation AUC = [0.5 +

+ (fdfo)\ x CT where fj = fluorescence reading at reading 1,

fn = fluorescence reading at reading n, and CT = reading time interval in minutes. The
data were analyzed using a Microsoft Excel (Microsoft, Redmond, WA) spreadsheet.
3. Trolox Equivalent Antioxidant Capacity (TEAC) Assay

The original TEAC assay was based on the activation of metmyoglobin with H2O2
in the presence of ABTS to produce radical cation, in the presence or absence of
antioxidants. This has been criticized on the basis that the faster reacting antioxidants
might also contribute to the reduction of the ferryl myoglobin radical. A more appropriate
format for the assay is a decolorization technique in that the radical is generated directly
in a stable form prior to reaction with putative antioxidants (Re et al. 1999). This
improved technique, which we used in our study (Appendix 3) involves the direct
production of the blue/green ABTS*+chromophore through the reaction between ABT
and potassium persulfate. This has absorption maxima at wavelength 734nm. Addition of
antioxidants to the pre-radical cation reduces it ABTS, to an extent and on a time-scale
depending on the antioxidant activity, the concentration of the antioxidant and the
duration of the reaction. Thus the extent of decolorization as percentage inhibition of the
ABTS*+radical cation s determined as a function of concentration and time and calculated
relative to the reactivity of Trolox as a standard, under the same conditions. The capacity
of the antioxidants in the sample to prevent ABTS oxidation is compared with that of
Trolox, a water-soluble tocopherol analogue, and is quantified as molar Trolox
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equivalents.This method is applicable to the study of both water-soluble and lipid-soluble
antioxidant.
G. Biomarkers of Lipid Peroxidation
1. Thiobarbituric Acid Reactive Substances (TEARS) Assay
Lipid peroxidation has been established as a major mechanism of cellular injury
in many biological systems of plant and animal origin. Peroxidation involves a process
whereby unsaturated lipids are oxidized to form additional radical species as well as toxic
by-products that can be harmful to the host system. Polyunsaturated lipids are especially
susceptible to this type of damage when in an oxidizing environment and they can react
to form lipid peroxides. Lipid peroxides are themselves unstable, and undergo aditional
decomposition to form a complex series of compounds including reactive carbonyl
compounds. Polyunsaturated fatty acid peroxides further react to form malonaldehyde
(MDA). MDA can be found in most biological samples including foodstuffs, serum,
plasma, tissues and urine, as a result of lipid peroxidation, and has become one of the
most widely reported analytes for the purpose of estimating oxidative stress effects on
lipids. The sensitivity of measuring TEARS has made this assay the method of choice for
screening and monitoring lipid peroxidation, a major indicator of oxidative stress. The
detailed procedure is shown in appendix 4.
The TEARS assay is based on the reaction of malondialdehyde (MDA) with
thiobarbituric acid (TEA); forming a MDA-TBA2 adduct that absorbs strongly at 532 nm.
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This reaction is the most commonly used method for estimating MDA in biological
samples.
H. Data Analysis
Results are expressed as both means ± SDs and means ± SEs. Changes between
the baseline (0 h) and different time intervals among groups were examined using
repeated-measures ANOVA. The difference between treatment groups and control group,
and also the effects of intervention on outcome parameters was analyzed by one-way
ANOVA.
I. Limitations
Results from this study could not be generalized to the whole American
population due to the geographical limitation of our study population. Lack of specific
lab equipment kept us from analyzing polyphenols into individual subgroups and we just
measured the total polyphenols content in plasma. Due to our time limitation, the direct
polyphenol content of nuts (walnut and almond) were not measured. The presence of
polyphenols in plasma could be better estimated by measuring 24-hour urine analysis,
which we didn’t perform in our study.
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Abstract
OBJECTIVE: To assess the acute effect of treatment meal (75% of energy from nuts,
walnut or almond) and a control meal (habitual diet with no nut consumption) in healthy
subjects on plasma total phenol content, antioxidant capacity, and plasma lipid
peroxidation.
DESIGN: Thirteen subjects participated in the crossover design study. After an overnight
fast, walnut, almond and a control meal, in the form of smoothies, were consumed by
study subjects. Each subject participated on three occasions one week apart, consuming
one of the smoothies each time. Blood samples were obtained at intervals up to 3.5h after
consumption of the smoothies.
RESULTS: Within 90 minutes of the consumption of the walnut and almond smoothies,
there was a significant increase in plasma total phenol content. Antioxidant capacity of
plasma determined by the ferric reducing capacity of plasma (FRAP) and oxygen radical
absorbance capacity (ORAC) reached its highest point at 150 min post-consumption of
the nut diet. Also, a gradual reduction in the susceptibility of plasma to lipid peroxidation
was observed 90 min after nut meals. No changes were observed following consumption
of control meal.
CONCLUSIONS: Consumption of nuts raises total phenol concentration, enhances the
antioxidant capacity of plasma, and reduces plasma lipid peroxidation . These findings
conclude that in addition to the favorable lipid profile of nuts, their phenolic content must
now be considered as a potential contributor to the apparent antithrombic, antioxidant,
anti-ischemic effects as well.
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Introduction
A correlation between nut consumption and a reduced incidence of ischemic heart
disease has been reported by several large epidemiological studies. Human intervention
studies (1-3) on nuts show that most of these cardio-protective effects of nuts are via
reducing both total and LDL cholesterol and unchanging HDL cholesterol. The presence
of unsaturated fatty acids is attributed to this cholesterol-lowering effect. However, nuts
have other healthful nutrients and non-nutrients such as fiber, vitamin E, polyphenols and
possibly other phytochemicals that can potentially contribute to reducing the risk of
cardiovascular disease (CVD). Polyphenols have been investigated in a variety of food
sources such as tea, wine, chocolate, fruits, and vegetables. In the last decade, numerous
in vitro and in vivo studies have shown that polyphenols from red wine (4) green tea (5)
and chocolate (6) can decrease the risk of CVD via two main functions: increase in
plasma antioxidant capacity and inhibition of LDL peroxidation (7-13). However, little is
known about the contribution of polyphenols in nuts to the body’s antioxidant status and
cardiovascular protection. Walnuts and almonds, the most consumed nuts in the United
States, contain favorable levels of total polyphenols relative to other foods, which have
not been studied thoroughly. The absorption, bioavailability of polyphenols administered
orally from nuts has not been adequately investigated, and to the best of our knowledge
have never been studied in the human body.
Thus, the primary purpose of this study is to investigate the kinetics of plasma
levels of total polyphenols and their effect on plasma antioxidant capacity and lipid
perxidation.
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Subjects and Methods
Subjects
Healthy subjects, seven men and seven women aged 19-65 were recruited using
advertisement flyers from Loma Linda University and surrounding areas. Subjects
underwent a screening in the form of person-to-person interview with the investigator.
Presence of any chronic disease, the use of any special diet, pregnancy, lactation,
smoking, BMI >25, the use of any medications or dietary supplements, allergies or
sensitivity to nuts were considered as exclusion criteria. Of the 14 subjects that started the
study, 13 completed the study and one person dropped out after the first clinic visit due to
lack of time. The study was approved by Institutional Review Board (IRB) of Loma
Linda University and all participants signed the informed consent form.
Study Design
A randomized (3x3) crossover design with one week wash-out period between
treatments (walnut, almond, and control) was used. Subjects were assigned to one of the
six different sequences of walnut, almond, and control meal. On the test day, subjects
arrived after an overnight fast and a fasting blood sample was taken. Then according to
the randomization schedule they were provided with one of three test meals for breakfast,
served in the form of smoothies. Smoothies had to be consumed within 10-15 minutes.
Blood samples were collected at 30, 90, 150 and 210 minute intervals after consumption
of the test meals. Participants refrained from consuming nuts, fruits, vegetables,
chocolate (any cocoa containing product), coffee, tea Juice (fruit or vegetable), and wine
24 hours prior to the clinic visit and during the study. Water consumption had no
limitation.
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Test meals
For the nut-containing meals, nuts provided 75% of energy intake (approximately
10 kcal/ kilogram body weight) and the remaining 25% of energy came from a refined
carbohydrate source. For the control meal, macronutrient composition similar to nutcontaining meals was calculated and food sources were carbohydrate (polycose), fat
(whipping cream and coconut oil), and protein (purified whey protein). Table 1 presents
diet composition for three test meals based on body weight.
Chemical Analyses
Blood samples were collected and plasma separated by centrifugation (1500 x g at
4°C for 10 min) and aliquots stored at -80°C until analyses.
Plasma Polyphenol Assay
Total phenolic content in plasma was measured by the Folin-Ciocalteau method
as modified by Serafini et al. (14) in order to remove protein interferences. Total phenolic
concentrations of plasma samples were determined after a procedure of acid
extraction/hydrolysis, and protein precipitation with 0.75 mol/L metaphosphoric acid
(MPA). For hydrolyzing the conjugated forms of polyphenols, hydrochloride acid (HC1)
was added to the sample, followed by sodium hydroxide (NaOH) in methanol. This step
breaks the links of polyphenols with lipids and provides a first extraction of polyphenols.
For removing plasma proteins MPA was in this procedure. The final extraction of
polyphenols was done by adding 1:1 (v/v) solution of acetone:water. The results were
expressed as milligrams gallic acid equivalent (GAE) per liter.
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Antioxidant Capacity Assay
Two methods were applied to measure the antioxidant capacity of plasma: the
ferric reducing ability of plasma (FRAP) assay as described by Benzie and Strain (15)
and the oxygen radical absorbance capacity (ORAC) developed by Cao and Prior (16)
and recently modified by Prior et al. (17).
Ferric Ion Reducing Antioxidant Power Assay (FRAP)
The FRAP assay takes advantage of electron-transfer reactions. The FRAP assay
was adopted from Benzie and Strain (15). This method measures the ferric reducing
ability of plasma. At low pH, when a ferric tripyridyltriazine (Fe III-TPTZ) complex is
reduced to the ferrous (Fe II) form, an intense blue color with an absorption maximum at
593 nm develops (15). Test conditions favor reduction of the complex and thereby, color
development, provided that a reductant (antioxidant) is present. Absorbance changes are
linear over a wide concentration range with antioxidant mixtures, including plasma and
with solutions containing antioxidants. The results expressed as pmol/L of antioxidant
power.
Oxygen Radical Absorbance Capacity (ORAC) Assay
The ORAC method with fluorescein as fluorescent probe was used as described
by Prior et al. (17). The method involves extraction and analysis of hydrophilic and
lipophilic antioxidants in plasma. The ORAC method is based on the inhibition of the
peroxyl-radical-induced oxidation initiated by thermal decomposition of azo-compounds
like 2,2'-azobis (2-amidino-propane) dihydrochloride (AAPH). This assay utilizes a
biological relevant radical source and is the only method that combines both inhibition
time and degree of inhibition into simple quantity.
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The assay uses area under the curve for quantification. The ORACfl values were
calculated by using a quadratic regression equation (y = ax2 + bx + c) between the Trolox
or sample concentration and net area under the FL decay curve. Data are expressed as
micromoles of Trolox equivalents (TE) per gram or per milliliter of sample (/Amol of
TE/g or ^mol of TE/mL). The area under curve (AUC) was calculated as AUC = [0.5 +
(f\/fo) + (fn/fo)] x CT where/; = fluorescence reading at cycle l,fn = fluorescence reading
at cycle n, and CT = cycle time in minutes. The data were analyzed using a Microsoft
Excel (Microsoft, Redmond, WA) spreadsheet.
Lipid Peroxidation Assay
The TEARS assay is based on the reaction of malondialdehyde (MDA) with
thiobarbituric acid (TEA); forming a MDA-TBA2 adduct that absorbs strongly at 532 nm.
This reaction is the most popular method for estimating MDA in biological samples.
TEARS are expressed as malondialdehyde equivalents. (18)
Statistical analysis.
Results in the text and tables are expressed either as means ± SEM or means ±
SD. Changes between the baseline (0 h) and other time points among treatment groups
were examined using repeated-measures ANOVA, with control for multiple
measurements on the same subjects. Where appropriate, multiple comparisons of the least
squares means were made using the Tukey-Kramer adjustment. Statistical significance
was assessed at the 5% level. All statistical analyses were performed using SAS for
Windows, version 8 (19).
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Results
Plasma total polyphenol, antioxidant capacity and lipid peroxidation results are
provided in Table 2. Plasma polyphenol concentration significantly increased within 30
minutes of the test meals with both walnut and almond, returning to the pre-consumption
basal levels by 210 minutes for the almond meal. No significant increase was observed
after consumption of the control meal and unexpectedly, there was even a decrease in
polyphenol plasma levels in response to the control meal, which persisted for the duration
of the experiment. Peak levels of total polyphenols were reached at 90 minutes after
ingestion for both nut meals (224.3 ± 2.57 mg GAE/L for the walnut meal and 238.48 ±
2.71 mg GAE/L for the almond meal). Increase in plasma polyphenol levels following
the intake of the walnut meal was more constant, and reached a steady state after 90
minutes and remained higher than baseline levels even at 210 minutes. For the almond
meal, following the 90 minute peak the levels returned to baseline levels by 210 minutes
(Figure 1.) At all time points (30, 90, 150 and 210 min) the walnut meal showed
significantly higher amounts of total plasma polyphenols over baseline, but this was not
the case for the almond meal.
Both nut meals demonstrated a significant increase in plasma antioxidant capacity
compared to the control meal measured by ORAC and FRAP assays (Table 2). The
percentage of change in both treatment groups reached a maximum at 150 minutes
following consumption of treatment meals, which declined toward baseline by 210
minutes. At 150 minutes after consumption of the walnut meal both lipophilic and
hydrophilic ORAC components represent about 123% and 201% increase of plasma
antioxidant capacity over baseline and this increase was about 363% after consumption of
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the almond meal (Figure 1.) The results for the control meal showed no significant
change over baseline at any time period after ingestion of the control meal.
Changes in the antioxidant capacity of plasma in response to the three test meals over
time were calculated as area under the curve (AUC). The AUC for the different assays of
antioxidant capacity is presented in Table 3. Data are presented for the time period of 0210 minutes. The AUC of the ORAC assay for hydrophilic components were
significantly higher for both walnuts and almonds compared to control, and lower for
walnuts compared to almonds.
With respect to plasma lipid peroxidation, consumption of the walnut and almond
meals resulted in a gradual reduction in the susceptibility of plasma to lipid peroxidation
measured by TEARS 90 minutes after ingestion (Table 2). In contrast, plasma that was
sampled of control group demonstrated no significant change over baseline.

Discussion
Our present study provides further evidence that beneficial effects of nuts are
more than lipid-lowering effects, which has been studied previously (1-3). Until recently
there has been no clear in vivo evidence that nuts are rich sources of polyphenols. The
present study has thus importantly demonstrated the antioxidant properties of almonds
and walnuts on human plasma. In the present in vivo study, for the first time, plasma
responses to two different nut-containing breakfast smoothies, walnut and almond, were
evaluated for polyphenol concentration, antioxidant capacity, and plasma lipid
peroxidation. We showed that polyphenols in walnuts and almonds can be detected in
blood postprandially and this detection can result in increasing plasma antioxidant
capacity and reducing plasma lipid peroxidation. The increase of total plasma polyphenol
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levels reached the peak point 30 minutes after consumption of both treatment meals,
however, walnut meal stayed more stable after 30 minutes compared to almond meal,
which dropped sharply after 30 minutes. Increases in antioxidant capacity of plasma
measured by ORAC and FRAP were observed for both treatment meals after 150
minutes. Almonds showed a greater antioxidant capacity compared to walnuts which can
be related to higher amounts of Vitamin E in almonds compared to walnuts. For the first
time, we have successfully obtained direct and indirect evidences of the absorption of
polyphenols in humans from walnuts and almonds.
Polyphenols were formerly studied in a variety of fruits and vegetables and our
findings compared well with data generated by other investigators, confirming that a
significant raise in total plasma antioxidant capacity is paralleled by the increase in
plasma concentrations of polyphenol compounds. Previous in vivo studies showed that
the antioxidant potential in humans responds to the oral ingestion of phenol-rich
beverages such as red wine (10) and tea (7). In agreement with Fuhrman et al. (9), we
showed that the reduced susceptibility of lipid peroxidation after dietary consumption of
polyphenol-rich food was associated with an increase in total polyphenol levels in
plasma. Lauder (20) has shown that the antioxidant activity of a phenol-rich beverage is
directly proportional to its polyphenol content. We can therefore reasonably assume that
the antioxidant effect observed in our in vivo study is caused by the polyphenol contained
in walnuts and almonds. The exact mechanisms and the sites of absorption of
polyphenols in humans are not clear. However, we speculated that due to a fast peak
point of 30 minutes post-consumption of treatment meals, the absorption of polyphenol
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might occur under the fasting conditions of our experiment, mainly in the in higher tract
of gastrointestinal system.
We were interested in walnuts and almonds because within the United States
these two nuts were the most consumed nuts among the other varieties and the
importance of antioxidant ability of these two nuts in risk reduction of many chronic
diseases could not be ignored. Future studies could work on other nuts that might go in
the same direction.
Our study like many other studies had limitations; the presence of polyphenols in
plasma could be better estimated by measuring 24-hour urine analysis, which we didn’t
perform in our study.
The addition of walnuts and almonds to the diet is a simple way to increase both
dietary and serum polyphenols and vitamin E. Moderate to high amounts of nut intake
have been demonstrated through epidemiological studies to confer some protection
against coronary heart disease. Heavy speculation concerning the protective mechanism
has focused upon the lipid-lowering effect of nuts. Our study adds to the current
knowledge that in addition to the favorable lipid profile of nuts, their polyphenol content
must now be considered as a potential contributor to the apparent anti-atherogenic
effects. These dual benefits of walnuts and almonds can be derived only from a whole
food. In conclusion, although more information on the bioavailability of polyphenol
compounds is necessary, our findings shed further light on the nature of the beneficial
effects of moderate nut consumption.
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Table L Diet composition for three test meals based on body weight

Body
Kcal
Weight needed
10
(kg)
cal/kg
wt

50
55
60
65
70
75
80
85
90
95

500
550
600
650
700
750
800
850
900
950

Control meal

Almond meal

Walnut meal

Walnut
(g)

CHO
(Polycose)
(ml)

Water
(floz)

Almond
(g)

CHO
Polycose
(ml)

Water
(floz)

Kraft
Whipped
Cream
(Cup)

Coconut
oil
(ml)

Whey
protein
(g)

Polycose
(g)

57
63
69
75
81
87
93
99
105
111

62
68
75
81
87
94
100
106
112
118

8
8
8
8
12
12
12
16
16
16

65
71
78
84
91
97
104
110
117
123

62
68
75
81
87
94
100
106
112
118

8
8
8
8
12
12
12
16
16
16

2.5
3
3
3.5
3.5
4
4
4.5
4.5
5

3.8
0.6
4.6
1.4
5.2
2.1
6
2.8
6.8
3.6

14
14.5
16
17
18.7
19.9
21.4
22.5
24
25.2

13
12
15.5
14.5
18
17
20.5
19.5
23
22.2
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Table 2. Plasma total polyphenols concentrations, total antioxidant capacity and lipid peroxidation in human subjects before
and after consuming walnut, almond and control meals
Plasma Lipid
Peroxidation
Plasma Total Antioxidant Capacity
Plasma Polyphenol
Test
Time
(pmol MDA/L)
(pmol/L)
(min)
(mg GAE/ L plasma)
Meal
FC2

ORAC
Hydrophilic2

ORAC Lipophilic2

FRAP2

TEARS2

200.28 ± 2.58
200.72 ± 2.49
208.44 ± 2.45
181.18 ± 2.71
171.56 ± 3.15

54.3 ± 1.02
64.4 ± 1.04
65.3 ±0.91
67.5 ± 0.95
65.9 ± 1.09

243.75 ±1.49
388.43 ± 1.23
356.87 ± 1.87
280 ± 1.35
262.5 ± 3.07

551.04 ±3.91
535.06 ±8.98
582.64 ±4.61
578.86 ±4.97
586.84 ±5.7

9.16± 1.8
11.19± 1.63
10.49 ± 1.56
10.5 ± 1.48
10.83 ± 1.8

147.56 ±2.7
209.72 ±2.51*
224.36 ± 2.57*
210.92 ±2.47*
208.24 ± 2.46*

58.6 ± 1.05
77 ± 1.12
103.9 ±3.32*
130.5 ±3.4*
100.8 ±2.39*

113.73 ± 4.51
194.37 ± 1.23
332.18 ±2.18*
455.31 ±3.79*
324.06 ± 1.76*

510.02 ±9
608.08 ± 5.99*
602.86 ±5.93*
635.04 ±7.15*
618.26 ±5.39*

9.14 ± 1.35
10.21 ±0.8
6.45 ± 0.8*
7.37 ±0.8
7.65 ± 0.8

187.2 ±2.53
230.08 ± 2.66*
238.48 ±2.71*
221.6 ±3.44
191.68 ±2.86

57.5 ± 1.43
102.5 ±3.6*
152.9 ±4.65*
266.2 ±8.68*
200.4 ±6.39*

123.67 ±3.67
215.62 ±2.54
375.93 ± 1.9*
472.5 ±3.83*
256.25 ± 2.07

525.2 ±9.81
604.84 ±8.16*
635.82 ±5.97*
657.4 ±6.75*
593.26 ±5.66*

Control
0
30

90
150
210
Walnut
0
30

90
150
210
Almond
0
30

90
150
210

Gallic Acid Equivalents
2Values are means ± Std.Dev, n =13
* Significantly different (P<0.05) from baseline
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7.3 ±0.8
7.62 ± 0.8
5.24 ±0.8*
6.26 ±0.8
6.16 ±0.8

Figure 1. Effect of control (♦), walnut (■) and almond (A) meal on total plasma
polyphenols measured by FC and plasma total antioxidant capacity measured by ORAC
and FRAP methods. Values expressed as percentage change of the individual increments
over baseline.
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Table 3. Diet comparisons of overall antioxidant capacity in plasma of human
subjects as indicated by the area under the curve (AUC, 0-210 minutes) following
three different meals
Methods

Meal comparison

FRAP

ORAC, lipo

ORAC, hydro

vs

Control

2736

805

700.7*

Almond vs

Control

3839

1135

2108.9*

Walnut vs Almond
-330
-1103
* significantly different using paired t-test (PO.05)

-1408.2*

Walnut
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Long term walnut supplementation without dietary advice induces favorable serum
lipid changes in free-living individuals
ABSTRACT
Walnuts have been shown to reduce serum lipids in short term well-controlled
feeding trials. No information exists on the sustainability of walnut consumption for
longer duration in a free living situation. A randomized crossover design in which 87
subjects with normal to moderate high plasma total cholesterol were initially assigned to
a walnut or control group for a six month period then switched to the alternate dietary
intervention and for a second six month period. Each subject participated in seven clinic
visits two months apart. At each clinic visit body weight was measured and in five of
these visits (Months 0, 4, 6, 10 and 12) a blood sample was collected. Our study showed
that supplementing a habitual diet with walnuts (12% of total daily energy intake
equivalent of 28-64 g/d) improves the plasma lipid profile. This beneficial effect was
more significant in subjects with high plasma total cholesterol at baseline. Significant
changes in serum concentrations of total cholesterol (P = 0.02 for diet effects),
triglycerides (P = 0.03 for diet effects) and LDL cholesterol (P = 0.06) were found. No
significant change was detected in either HDL cholesterol (P = 0.72) or LDL to HDL
ratio (P = 0.58). We concluded that the inclusion of walnuts as part of a habitual diet
favorably altered the plasma lipid profile. The lipid lowering effects of walnuts were
more evident among subjects with higher lipid baseline values, precisely in those people
with greater need of reducing plasma total and LDL cholesterol.
Key words: walnuts, total cholesterol, triglyceride, LDL cholesterol, randomized trial
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It is widely recognized that diet is one of the important factors in lowering the
risk of cardiovascular disease. Dietary guidelines for cardiovascular disease prevention
emphasize the reduction of fat intake or replacement of saturated fatty acids by
unsaturated fatty acids (1). Another approach that might invigorate current knowledge is
the possibility of adding a whole food to the currently existing diet that obtains the same
beneficial effect. Nuts, as a whole food, have received particular attention because of the
epidemiological association of their frequent intake with protection from coronary heart
disease (2-8). Walnuts have a high fat content, as do other nuts, but are low in saturated
fatty acids (SFA). Walnuts have consistently reduced serum cholesterol and improved the
lipoprotein profile in several well-controlled short-term clinical trails (9-12). Recently,
the FDA has issued a qualified health claim which says “Supportive but not conclusive
research shows that eating 1.5 ounces per day of walnuts, as part of a low saturated fat
and low cholesterol diet may reduce the risk of coronary heart disease.” Considering
previous research on walnuts, there are several questions that remained unanswered: (1)
if the lipid lowering effect of walnut consumption in the short term can be maintained
and extended to a long term period; (2) if people can sustain a diet with walnuts for a
longer duration; and (3) if lipid the lowering effect of walnuts can be seen when
participants are in a free-living situation and no dietary advice is given to them. We
designed a long-term study in which free-living adults participated to compare the effects
on serum lipid and lipoprotein levels of a walnut-supplemented diet with those of a
habitual diet.
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SUBJECTS AND METHODS
Subjects
One hundred thirteen non-smoking men and women aged 30-72 years were
recruited from Southern California communities using advertisement flyers. They all
underwent a selection process, which included two telephone interviews, an
informational meeting and a person-to-person interview. Subjects were eligible if they
met the following inclusion criteria: (i) apparently healthy as indicated by a general
'y

medical questionnaire, (ii) body mass index (BMI) <30 kg/m ; (iii) not allergic or
sensitive to nuts; (iv) not pregnant or lactating; (v) eager to keep a habitual diet similar to
a typical American diet, willing to not consume any other nuts during the study; and not
follow a weight-reducing diet; and (vi) not taking any lipid lowering medication and/or
dietary supplements. After the selection process, 94 people started the study. Two of the
94 participants dropped out due to compliance difficulty, two were dropped when
diagnosed with a metabolic disorder at the time of the study, and three were excluded
from the statistical analysis because they were found to be taking lipid-lowering
medications. Thus, a total of 87 people, 49 females and 38 males aged 30 to 72 years,
comprised the analytic study population. The study protocol was approved by
institutional review board (IRB) prior to the study. All volunteers signed a written
informed consent before beginning the study and were free to withdraw from the study at
any time without obligation.
Study design
This study utilized a randomized crossover design in which subjects were initially
assigned to a walnut or control group for the first six months. The subjects were then
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crossed over to the alternate dietary intervention and continued for the second six months.
A crossover design was used to eliminate ordering effects. Each subject participated in
seven clinic visits two months apart. At each clinic visit body weight was measured and
in five, of these visits (Months 0, 4, 6, 10 and 12) blood samples were collected.
Diet
Those assigned to the walnut group were expected to consume the provided
amount of walnuts (12% of total energy intake), which was the equivalent of 28-64 g/d
based on individual characteristics such as gender, height, weight, age, and level of
physical activity. The total energy need for each participant was estimated with the HarrisBenedict equation prior to the study. For subsequent clinical visits, the prescribed walnut
amount was adjusted based on the daily energy intake as assessed by 24-hour dietary
recalls. Conversely, the control group was advised to continue their habitual diet and
refrain from eating walnuts and substantial amounts of any other nuts during this period.
Daily amounts of walnuts were provided in individual packages and subjects were
instructed to consume the walnuts every day. Subjects were advised to avoid additional
walnut consumption outside of that provided by the study and to maintain their regular
diets. To prevent confounding, we instructed the participants not to change their physical
activity and dietary intake, and not to attempt to lose weight while in the study. No other
dietary guidance was given to keep the study as free-living as possible.
Compliance
Compliance is defined as non-intake of walnuts (intake < 2g) during the control
period and intake of the allotted amounts of walnuts (intake > 28g) during the walnutsupplemented period. To ensure whether the subjects had eaten all their supplied walnuts
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and whether they had consumed nuts other than those that were provided, 14 dietary
recalls were collected for the entire 12-month study. Seven recalls were collected during
each six month period. Recalls included two weekend days and five nonconsecutive
weekdays, in order to capture daily variations in intake. Dietary recalls were
unannounced and administered non-consecutively to reduce the possibility of subjects
changing their intake. Nutrient intake was evaluated using Nutritional Data Systems
software (NDS-R) Version 5.0, developed by the Nutrition Coordinating Center,
University of Minnesota, Minneapolis, MN, Food and Nutrient Database 29.

Blood sample collection and body weight measurement
On the morning of each visit, the subjects attended the clinic after 12 hours of
fasting. Whole blood was collected into tubes containing EDTA to determine plasma
lipids. Plasma was separated by centrifugation at 1500 x g for 20 min at room temperature
within one hour of extraction. The resulting plasma was frozen at -80°C and shipped in
batches to the Laboratory for Clinical Studies (University of Connecticut, Department of
Nutritional Sciences). Plasma total cholesterol, HDL-C, and TAG were determined using
methods previously reported (13), and LDL-C was calculated using the Friedewald
formula (14). CVs assessed by the Standardization Program during a recent study were
0.76-1.42% for total cholesterol, 1.71-2.72% for HDL-C, and 1.64-2.47% for TG. Total
red cell fatty acids were extracted with isopropanol and chloroform according to the
method of Rose and Oklander (15). Body weight was also measured at baseline and at
each clinic visit to account for the potential influence of this factor on plasma lipid levels.
Weight measurements were recorded to the 0.1 of a kilogram. Subjects were weighed
twice and the mean was used for data analysis (16).
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Statistical analysis
Our primary interest was the contrast between the walnut and control diet in the
main outcomes of total cholesterol, triglycerides, LDL and HDL cholesterol, and the ratio
between LDL and HDL cholesterol. For each outcome the between-diet differences in
end-of-period measurements was considered. SAS 9.1 (17) was used for all statistical
analyses (PROC MIXED procedure). Data are given as means ± SE. Changes from
baseline were used as the dependent variables. If the original data were of approximate
normal distribution, then changes from baseline were calculated on the original scale; if a
log transform was deemed appropriate, then changes from baseline were calculated on the
log scale, and these changes then corresponded to a multiplicative change from the
baseline original scale. Statistical significance was defined by P<.05 (2-sided) with and
without adjustment for body weight.
RESULTS
Table 1 presents descriptive characteristics of study participants at baseline
according to dietary sequence. Forty four percent of study participants were male. The
average age was 54 years old and mean BMI, weight and height were 26.5 (kg/m2), 75.6
(kg) and 169.5 (cm), respectively. Compliance was assessed at the end of each dietary
period by measuring the concentration of two essential fatty acids, linolenic and otlinolenic, in the erythrocyte membrane. Across the treatment sequence groups and the
diet periods, degree of compliance was excellent at about 95%. Of the 87 subjects, 67.5%
showed an increase in the red blood cell of linoleic acid and a 90% increase was found in
oc-linolenic acid. The sum of both fatty acids was 68% higher during the walnut diet
compared to the values during the control diet.
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After evaluating the 24-dietary recalls and compliance method, we found that
subjects while on the walnut-supplemented regimen had a higher total energy
consumption, 8171 kJ (1952 kcal), than during the control period, 7614 kJ (1819 kcal).
The mean difference between daily total energy intake during the two diet periods (mean
[SE] = 557 [142] kJ {133 [34] kcal}) is less than the actual energy intake from walnuts
(967 kJ [231 kcal]).
The effects of the two diets on serum lipid and lipoprotein concentrations are
given in Table 2. Significant changes in serum concentrations of total cholesterol {P =
0.02 for diet effects) and triglycerides {P = 0.03 for diet effects) were found. Effects on
LDL (E* = 0.1) and HDL cholesterol {P = 0.47) and ratio between LDL and HDL {P =
0.85) concentrations did not differ between the two diets.
After adjusting for body weight, the effects of the walnut and control diets on
serum lipid and lipoprotein concentration showed a significant change in serum
concentrations of total cholesterol (P = 0.01), LDL cholesterol (P = 0.06) and
triglycerides {P = 0.01). Results are shown in Table 2. No significant change was
detected in either HDL cholesterol (P = 0.72) or LDL to HDL ratio (P = 0.58).
Figure 1 presents the estimated difference of effect between the walnut and
control diets on plasma total and LDL cholesterol, and the LDL cholesterol to HDL
cholesterol ratio according to the plasma total cholesterol values at baseline. After
adjusting for body weight, a statistically significant diet-baseline value interaction effect
was observed for overall total cholesterol (P-value for interaction = 0.018), LDL
cholesterol {P-value for interaction = 0.014), LDL cholesterol and HDL cholesterol ratio
{P-value for interaction^.001). Compared with the control diet, lipid-lowering effect of
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walnuts was magnified in subjects with higher baseline total cholesterol levels. All blood
lipid components showed a significant reduction at the 80th percentile after walnut
ingestion. For total cholesterol, results were significant at the 60 (T05.87 mmol/L)^
=0.005) and 80th percentile (TC>6.38 mmol/L) (P = <0.001) whereas in the 20th
percentile (TC<4.94 mmol/L) total serum cholesterol concentrations did not differ
between the two diets (P = 0.88). In both serum LDL cholesterol and LDL to HDL
cholesterol ratio significant diet-baseline interaction effect was observed at the 80th
percentile. No significant change was observed for either triglycerides or HDL
cholesterol in any of the two diet groups.
DISCUSSION
In this 12-month crossover dietary intervention trial on 87 free-living adults with
normal to moderate high plasma total cholesterol, we found that supplementing walnuts
for approximately 12% of total daily energy intake without changing habitual diet
decreases total cholesterol and triglyceride levels. The beneficial effects of walnuts were
more evident in subjects with higher baseline total cholesterol values. Since the main
purpose of this 12-month crossover feeding trial was to investigate the long-term effect of
walnut consumption on body weight change (18), no intentional dietary modifications
were applied during the study. Thus, adjusting for changes in body weight (-0.5-0.4 kg)
provides the best estimate of the dietary effects on blood lipid.
In previous studies, nuts were used to replace other form of fat such as animal fat
and saturated fat (19-22). Our study was the first which was designed to add walnuts to a
currently existing diet and use a “free-living” situation for a longer duration. Our findings
showed that without adjusting for body weight, total cholesterol and triglyceride levels
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were both significantly reduced in free-living subjects on a walnut supplemented diet
compare to their habitual diet.
After adjusting for body weight, in addition to total cholesterol and triglyceride,
LDL cholesterol showed a significant reduction of 3% between walnut and control group.
Furthermore, according to baseline values of plasma total cholesterol, the highest
reduction was seen in the 80th percentile for total cholesterol, LDL cholesterol and the
ratio between LDL and HDL cholesterol compared to other percentiles. This outcome
showed the more cholesterol-lowering effect of walnuts in people who started the study
with higher baseline values of total cholesterol compare to those with low or moderate
plasma total cholesterol levels. This means hyperlipidemic people may benefit the most
by incorporating walnuts into their diets.
After evaluating the 24-dietary recalls and compliance method, first we found that
subjects while on the walnut-supplemented diet had a higher total energy consumption,
than during the control period. The mean difference between daily total energy intake
during the two diet periods is less than the actual energy intake from walnuts, which
suggests partial substitution of other foods in the walnut-supplemented diet. Second, we
found an excellent (95%) degree of dietary compliance, which represents that people can
sustain a diet with walnuts for six months.
The lipid lowering effects of walnuts that we found in our study were consistent
with prior reports (11, 23-25) showing that a walnut diet decreases total cholesterol
levels, in particular in subjects with higher baseline plasma total cholesterol levels (26).
No significant change was observed in HDL cholesterol between the two diets, which is
in broad agreement with previous work (22-23).
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Walnuts have many beneficial attributes. The cardio-protective effect of walnuts
due to a high amount of polyunsaturated fatty acids (PUTA) is the foremost at this time.
There may be a number of other bioactive compounds in nuts such as vitamin E, fiber,
phytochemicals or polyphenols that potentiate cholesterol-lowering effects and
independently affect risk factors for various chronic diseases. However, the data on this
topic are limited and much research is needed to define the roles that these compounds
may play in reducing the risk of chronic diseases, as well as the biological mechanisms
involved. Sufficient data is available to justify the recommendation to include nuts in the
diet. As discussed, nuts can be readily incorporated into the diet. Efforts are needed to
educate the public about the health benefits of nuts and ways to use them in planning a
healthy diet.
In summary, the inclusion of walnuts as part of a habitual diet favorably altered
the plasma lipid profile. The lipid lowering effects of walnuts were more evident among
subject with higher lipid baseline values, precisely in those people with greater need of
reducing plasma total and LDL cholesterol.
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Table 1. Descriptive characteristics of study participants at the beginning of the 12 month
walnut-control diet study1.
P-value

Diet Sequence

Characteristics

w/c

C/W

55.3 ±10.28

52.8 ± 11.33

0.27

62

50

0.25

Weight (kg)

72.3 ± 12.79

79.1 ± 15.11

0.02

Height (cm)

166.4 ±8.55

170.7 ± 11.73

0.05

BMI (kg/m2)

26.1 ±3.57

26.9 ± 3.28

0.22

Fat %

31.4 ±7.22

30.5 ±6.91

0.57

Total cholesterol (mmol/L)

5.62 ±0.79

5.82 ±0.86

0.25

LDL cholesterol (mmol/L)

3.21 ±0.79

3.51 ±0.92

0.10

HDL cholesterol (mmol/L)

1.57 ±0.37

1.48 ±0.42

0.20

LDL: HDL

2.21 ±0.83

2.51 ±0.97

0.05

1.42 ±0.80

0.78

Age (y)
Gender (% female)

Lipid values at baseline

Triglycerides (mmol/L)
1.36 ±0.75
All results are expressed in means ± SD except gender
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Table 2. Fasting serum lipid and lipoprotein concentrations and the ratio of LDL to HDL cholesterol during consumption of
Blood Lipids

Diet

Adjusted Values2"

Crude Values"

Walnut

Control

Estimated Effect

P-value

Estimated Effect

P-value

Total Cholesterol

5.41 ±0.09

5.54 ±0.09

-0.13 ±0.08

0.02*

-0.18 ±0.07

0.01

LDL Cholesterol

3.29 ±0.09

3.38 ±0.09

-0.09 ± 0.05

0.10

-0.16 ±0.09

0.06*

HDL Cholesterol

1.50 ±0.04

1.51 ±0.04

-0.01 ±0.01

0.47

-0.02 ± 0.05

0.72

LDL: HDL4

2.38 ±0.10

2.44 ±0.10

-0.06 ± 0.03

0.85

-0.07 ± 0.01

0.58

Triglycerides4

1.35 ±0.05

1.44 ±0.07

-0.09 ± 0.04

0.03*

-0.16± 0.06

0.01*

♦

oo

walnut and control diets for six months by healthy, free-living men and women7
; All values are Mean± SE in (mmol/L); « = 87 (38 men and 49 women).
2 The values are adjusted for body weight
3 Analysis was performed on log transform values. Results are shown in original unit for ease of interpretation
a Control-diet values are subtracted from walnut-diet values
Statistically significant in walnut-diet group compare to control-diet group
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Figure 1. Estimated difference of effect between walnut and control diets in plasma total
and LDL cholesterol, and LDL to HDL ratio according to plasma total cholesterol
baseline values
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CHAPTER 6
CONCLUSIONS
A. Summary and Limitations of the Study
In the present in vivo study, for the first time, plasma responses to two different
nut-containing breakfast smoothies, walnut and almond, were evaluated for polyphenolic
concentration, antioxidant capacity, and plasma lipid peroxidation. We showed that
polyphenols in walnuts and almonds can be detected in blood postprandially and this
detection can result in increasing plasma antioxidant capacity and reducing plasma lipid
peroxidation. Our findings are strongly related to lowering the risk of many chronic
diseases such as heart disease, stroke, cancer and diabetes. Several previous studies on
nuts had shown the lipid-lowering effects of nuts (Fraser, Sabate, Beeson & Strahan
1992; Hu et al. 1998; & Kushi et al. 1996). Our study complements previous findings
showing the anti-oxidative effects of almonds and walnuts. Antioxidant compounds were
formerly studied in variety of fruits and vegetables, however, nut polyphenols and their
role as in vivo nutritional antioxidants was not previously examined. Our study showed
that fruits and vegetables are not the only rich source of polyphenols; nuts are one of the
most superb sources of polyphenols as well. Almonds and walnuts have high amounts of
polyphenols which can be easily digested, absorbed, and enter the blood circulation with
positive effects on antioxidant capacity and inhibition of lipid peroxidation. This study
provides novel evidence for the absorption of polyphenols into the blood stream after the
ingestion of these two types of nuts. Our study has irrefutably shown that the beneficial
effect of nuts is more than a lipid lowering effect. The emphasis on nut consumption must
be on two different issues from this time forward, (1) heart-healthy lipid profile and high

86

concentration of vitamin E; and (2) high polyphenols concentration as a representative of
anti-oxidative agent. We were interested in walnuts and almonds because within the
United States these two nuts were the most consumed nuts among the other varieties and
the importance of antioxidant ability of these two nuts in risk reduction of many chronic
diseases could not be ignored. Future studies could examine other nuts and their
additional effects. Our study, like all other research studies, had specific limitations; for
example lack of specific lab equipment kept us from analyzing polyphenols into
individual subgroups and we just measured the total polyphenols content in plasma. The
presence of polyphenols in plasma could be better estimated by measuring 24-hour urine
analysis, which we didn’t perform in our study. One assumption was made in our study
following the consumption of walnut and almond meals that the transient increase in
plasma total phenol content might indicate that polyphenol absorption could occur, under
the fasting conditions of our experiment, mainly in the upper tract of the gastrointestinal
system and, in lesser amounts, in the jejunum. What happens to the dietary phenols that
escape absorption in these regions and progress toward the colon is still unclear. The
exact mechanisms and the sites of absorption of polyphenols in humans require further
investigation.
B. Future Studies
Since polyphenol bioavailability would vary in human subjects, further clinical
studies with more than 13 subjects should be investigated. Dietary interventions with
polyphenols consumed for extended time periods would also be useful to evaluate if
intact polyphenols bioaccumulate in humans. Additionally, studies on the detection of
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polyphenols metabolites, methods to increase their bioavailability, and strategies to
increase their concentration in blood and target tissues are warranted.
C. Conclusion and Implications of Findings
We have successfully obtained direct and indirect evidence of the absorption of
polyphenols in humans from walnuts and almonds for the first time. In conclusion, we are
suggesting that the addition of walnuts and almonds to the diet is a simple way to
increase both dietary and serum polyphenols and some other important antioxidants such
as vitamin E. Implication of our study for general population is that nuts and seeds could
become a natural part of the diet of every individual. The current in vivo data on
polyphenol-rich diets used at expected physiologic concentrations demonstrate their
potent antioxidant capacity with plasma and contribute to the overall understanding of
how dietary-derived polyphenols may participate in the complex antioxidant network.
Antioxidant characterization of the walnut and almond adds to current knowledge of
polyphenol distribution in foods. In addition to the favorable lipid profile of nuts, their
polyphenol content must now be considered as a potential contributor to the apparent
anti-atherogenic effects of nuts. These dual benefits of walnut and almond can be derived
only from a whole food. In conclusion, although more information on the bioavailability
of phenolic compounds is necessary, our findings shed further light on the nature of the
beneficial effects of moderate nut consumption.
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Appendix 1.
Meal diets composition (Walnut, Almond and Control) based on body weight
Body
Weight (kg)

Kcal needed
10 cal/kg wt

75% kcal
from nuts

50
55
60
65

500
550
600
650

375
413
450

70

700

75

750

80

800

85
90
95

850
900
950

525
563
600
638
675
713

Almond (g)

57 (2 oz)

65 (2.3 oz)
71

63
69
75
81

488

87

93
99
105
111

78
84

91
97
104
110
117
123

% Fat

% Protein

% CHO

75%
Total Kcal

86

7.5

6.5

75%
Total Kcal

78

12

10

82

10

8

Nuts

Kcal

Walnut

Almond

Average of
both nuts

Walnut (g)
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Walnut Shake formula
Body
Weight
(kg)

Kcal
needed
lOcal/kg
wt

75% kcal
from nuts

25% Kcal
remaining

Walnut

CHO
(Polycose)

Water

8
(leup)
8
8
8
12(1.5
cups)
12
12
16(2
cups)
16
16

(floz))

(g)

50
55
60
65
70

500
550
600
650
700

375
413
450
488
525

125
137
150
162
175

57 (2 oz)
63
69
75
81

31 g* = 62
ml
68 ml
75 ml
81 ml
87 ml

75
80
85

750
800
850

563
600
638

187
200
212

87
93
99

94 ml
100 ml
106 ml

90
95

900
950

675
713

225
237

105
111

112 ml
118 ml

*lg polycose = 4kcal, 1ml = 2 kcal

Overall nutrient component of Walnut shake (75% walnuts & 25% CHO)
Nutrients

%

Fat
Protein
CHO

64.5
5.5
30
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Almond Shake Formula
Body
Weight
(kg)

Kcal
needed
lOcal/kg

75%kcal 25%Kcal
from nuts remaining

Almond (g)

Polycose
(CHO)

Water
(floz))

31 g =
62 ml
68 ml
75 ml
81 ml
87 ml

8
(leup)
8
8
8
12(1.5
cups)
12
12
16(2
cups)
16
16

wt
50
55
60
65
70

500
550
600
650
700

375
413
450
488
525

125
137
150
162
175

65 (2.3 oz)
71
78
84
91

75
80
85

750
800
850

563
600
638

187
200
212

97
104
110

94 ml
100 ml
106 ml

90
95

900
950

675
713

225
237

117
123

112 ml
118 ml

Overall nutrient component of almond shake (75% almonds & 25% CHO)
Nutrients

%

Fat
Protein
CHO

58.5
9
32.5
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Control Shake Formula
Body
Weight

Kcal
needed

Kcal

(kg)

10
cal/kg
wt
500
550
600
650
700
750
800
850
900
950

310
341
372
403
434
465
496
527
558
589

50
55
60
65
70
75
80
85
90
95

Kcal

Kcal

from

from

from

fat

Pro

CHO

35
38.5
42
45.5
49
52.5
56
59.5
63
66.5

155
170.5
186
201.5
217
232.5
248
263.5
279
294.5

Kraft
Whipped
Cream

Coconut
oil

Whey
protein

Polycose

(Cup)

(ml)

(g)

(g)

2.5
3
3
3.5
3.5
4
4
4.5
4.5
5

3.8
0.6
4.6
1.4
5.2
2.1
6
2.8
6.8
3.6

14
14.5
16
17
18.7
19.9
21.4
22.5
24
25.2

13
12
15.5
14.5
18
17
20.5
19.5
23
22.2

1 cup Kraft whipped cream = 148 kcal (111 kcal fat, 35.5 kcal CHO, 1.48 kcal pro)
28 g (loz) Whey protein = 108 kcal (6.48 kcal fat, 31.3 kcal CHO, 65.88 kcal pro)
12 TS (% cup) coconut oil = 470 kcal (470 kcal fat)
Ig polycose = 4 kcal (4 kcal CHO)
Amount of added water for this diet was very similar to the treatment diets and it was
based on subject’s body weight.
1 cup water
1. body weight 50-65 kg
1.5 cups water
2. body weight 70- 80 kg
3. body weight 85-95 kg
2 cups water
Overall nutrient component of control shake based on average of both nuts
Nutrients

%

62
7
31

Fat
Protein
CHO
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Appendix 2.
Folin-Ciocalteau (FC) Assay
(Serafini et al. J. Nutr 128:1003-7, 1998)
•

FC Chemical required

0.75 mol/L Metaphosphoric acid (MPA): (FW = 80, 35% MPA) (100ml)
gMPA = 0.75 x 80x0.1 =6 g
6gx 100/35% = 17 g
Dissolve 17 g of MPA in 100 ml distilled water
2 mol/L NaOH in 75% methanol: (100ml)
g NaOH = 2 x 40 x 0.1 = 8g
Dissolve 8 g NaOH in 20ml of distilled water. Add methanol to make up 100ml
1 mol/L Hcl: (100ml) (FW = 36.5, %Hcl 37.8, sp gravity = 1.2)
g Hcl = 1 x 36.5 x 0.1 = 3.65 g
3.65 x 100/37.8 = 9.65
Vol = 9.65 /1.2 = 8 ml
8ml Hcl in 100ml distilled water
FC Reagent:
Dilute the concentrated commercially prepared reagent (Merck, Sigma etc) 1:10
with distilled water. Prepare fresh daily
Standard Solution: Gallic acid standard (500mg GAE/L:
To prepare 100ml of standard:
Dissolve 0.05 g of gallic acid in 10 ml of methanol
Make up solution with distilled water to 100 ml
Dilute: 1 to 5, 1 to 10 and 1 to 20
•

Extraction of total polyphenols from plasma/serum (Acid Hydrolysis)
1. 5 00pL plasma/serum
2. Add 1 ml of 1 mol/L Hcl
3. Vortex 60 seconds
4. Incubate at 37°C for 30 minutes
5. Add 1 ml of 2 mol/L NaOH in 75% methanol
6. Vortex three minutes
7. Incubate at 37°C for 30 minutes
8. Add 1 ml of 0.75 mol/L metaphosphoric acid (MPA)
9. Vortex three minutes
10. Centrifuge at 1500 x g for 10 minutes
11. Remove 2 ml of supernatant
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12.
13.
14.
15.

Add 1 ml of 1:1 (v:v) solution of acetonerwater
Vortex one minute
Centrifuge at 2700 x g for 10 minutes
Remove 1 ml of supernatant

• Procedure of polyphenol measurement
(Singleton et al. Methods in Enzymology 299:152,1999)
In clean test tubes:
1.
2.
3.
4.

5.
6.
7.

200pL sample, standard, blank
800pL distilled water
200pL FC reagent
Let sit for one minute and not more than eight minutes
Add 800pL of sodium carbonate (75g/L)
Let sit in dark at room temperature for six hours
Read absorbance at 765nm
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Appendix 3.
Ferric Ion Reducing Antioxidant Power Assay (FRAP)

FRAP Chemical required
Acetate Buffer: 300mM, PH 3.6
3.1g sodium acetate.3 H2O
16ml glacial acetic acid
Distilled water to 1 liter
Check PH, store at 4°C
Dilute HCl:

40mM
1.46ml cone. HCl (11M)
Distilled water to 1 liter
Store at room temperature

TPTZ (2,4,6-tri[2-pyridyl]-s-triazine): lOmM
0.03 Ig TPTZ in 10ml of 40mM HCl, dissolve at 50°C in water bath
Make fresh on day of assay

Ferric chloride: 20mM
0.054g FeCl3. 6H20
Dissolve in 10ml distilled water
Make fresh on day of assay

Standard : Trolox (6 Hydroxy-2,5,7,8-tetramethylchorman-2-carboxylic acid): lOOOpM
To make 100ml
0.025g of Trolox in 100ml distilled water
Dilute as follows to make series of standards:
Distilled water (ml)
Stock
Standard concentration (pM) Trolox (ml)
1
0
1000 (as is)
1
1
500
1
2
3
1
250
3
7
1
4
125
Freeze at -20°C in 10ml aliquots
FRAP Reagent*:
200ml acetate buffer
20ml TPTZ solution
20ml FeCls solution
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24ml distilled water
* Wrap final solution in foil and store in below room temperature conditions until actual use

FRAP Method
(Adapted from Benzie & Strain, 1996, Analytical Biochemistry, 239, 70-76)

1. Switch water bath and spectrophotometer on
2. Defrost samples and standards
3. Set the spectrophotometer at 593nm, the temperature should be
37°C. Set the timer for five minutes for each run.
4. Blank: run a set of blanks first. Add distilled water to six cuvettes
and place them all in the machine.
5. Standards: 3ml FRAP reagent + IOOjiL standard
6. Run a set of standards (different stocks)
a. Samples: 3ml FRAP reagent + lOOpL sample
Always use one cuvette for blank. The other five cuvettes are for samples. Run each
sample duplicate. The machine will automatically subtract blank from sample/standard
values.
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Appendix 4.
ARTS (TEAC) chemical required
ABTS solution: 100ml of ABTS + potassium persulfate in 100ml phosphate buffered
saline 5mM PH 7.4
1. ABTS (2,2-azinbois(3-ethylbenzothiazoline-6-sulfonic
acid) (FW = 548.7)
g = 0.007 x 548.7 x 0.1 = 0.384 g ABTS in 100ml distilled water
2. Potassium Persulfate (FW = 27.3)
g = 0.00245 x 270.3 x 0.1 = 0.066g potassium persulfate in 100ml phosphate
buffered saline 5mM PH 7.4
Allow the ABTS mixture to stand in the dark at room temperature for 12-16 hours before
use
Dilute ABTS mixture with PBS (PH 7.4) to an absorbance of 0.70 ± 0.02 at 734nm (1ml
ABTS to 80-100ml PBS)
Standard: Trolox (6 Hydroxy-2,5,7,8-tetramethylchorman-2-carboxylic acid): 2000pM
To make 100ml
0.05g of Trolox in 100ml distilled water
Dilute as follows to make series of standards:
Standard concentration (pM)
Stock

1
2
3
4

2000 (as is)
1000
500
250

Trolox (ml)
1
1
1
1

Distilled water (ml)

0
1
3
7

ABTS (TEAC) Procedure
(Adopted from Re et al.(1999) Antioxidant activity applying an improved ABTS radical cation
decolorization assay. Free Radic Biol Med; 26(9-10): 1231-7.)

After switching water bath and spectrophotometer on
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i. Defrost samples and standards
ii. Dilute samples: 1ml final sample = V2 ml original sample + V2 ml
PBS
. iii. Set the spectrophotometer at 734nm, the temperature should be
30°C.
Set the timer for five minutes for each run.
iv. Blank: run a set of blanks first. Add distilled water to six cuvettes
and place them all in the machine.
v. Standards: 1ml ABTS solution + lOpL standard
Run a set of standards (different stocks)
vi. Samples: 1ml ABTS solution + lOjiiL sample
Always use one cuvette for blank. The other five cuvettes are for
samples. Run each sample duplicate. The machine will automatically
subtract blank from sample/standard values.
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Appendix 5.
Thiobarbituric Add Reactive Substances (TEARS) Assay
(Oteiza et al. Neurochem Res 22:535-539, 1997)
•

TEARS Chemical required

3% Sodium Dodecyl Sulfate (SDS):
3g of SDS in 100 ml distilled water
Hcl 0.1 M: (FW = 36.5, %Hcl 37.8, sp gravity = 1.2)
g= 0.1 x 36.5 x 0.1 = 0.365
0.365 gx 100/37.8 = 0.965
volume (ml) = 0.965/1.2 = 0.8 ml
0.8 ml in 100 ml distilled water
Phosphotungstic acid (10% wt/v):
10 g Phosphotungstic acid in 100 ml distilled water
2-Thiobarbituric acid (0.7% wt/v):
0.7 g 2-thiobarbituric acid in 100 ml distilled water
Standards:
Stock standard-tetramethoxypropane (TEP) 10/imolar
Std 1.
Std 2.
Std 3.
Std 4.

•

1.66 mg of TEP and add 1-butanol to make-up 100 ml (Keep in freezer)
50 pi stock Std 1. in 10 ml 1-butanol
25 pi stock Std 2. in 10 ml 1-butanol
10 pi stock Std 3. in 10 ml 1-butanol

Procedure of Inhibition of Lipid Peroxidation
1. Pipette 50 pi standards and plasma into tubes
2. Add:
a. 100 pi of 3% SDS
b. 400 pi of 0.1 mol/L Hcl
c. 50 pi 10% (wt/v) Phosphotungstic acid
d. 200 pi 0.7% (wt/v) 2-Thiobarbituric acid
3. Vortex
4. Heat at 95 °C for 1 hour
5. Cool
6. Add 500 pi of 1-butanol in HOOD
7. Vortex
8. Centrifuge 1800 RPM for 10 min
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9. Remove 150 jil aliquot of the butanol phase to 96 well place
10. Analyze spectroflurometrically (excitation 515 nm and emission 555
nm) using the plate reader
11. TEARS are expressed as malondialdehyde (MDA) equivalents
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